Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)


☑			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2024


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 001-15169

PERFICIENT, INC.

(Exact name of registrant as specified in its charter)

Delaware

No.

74-2853258

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

555 Maryville University Drive

Suite 600

Saint Louis, Missouri 63141

(Address of principal executive offices)

(314) 529-3600

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.001 par value	PRFT	The Nasdaq Global Select Market

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements during the past 90 days. þ Yes o No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). þ Yes o No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.


Large accelerated filer	þ	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ

As of July 25, 2024, there were 35,156,654 shares of Common Stock outstanding.

TABLE OF CONTENTS


Part I.	Financial Information	1

Item 1.	Financial Statements	3

	Condensed Consolidated Balance Sheets as of June 30, 2024 (unaudited) and December 31, 2023	3

	Unaudited Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2024 and 2023	4

	Unaudited Condensed Consolidated Statements of Comprehensive Income for the Three and Six Months Ended June 30, 2024 and 2023	5

	Unaudited Condensed Consolidated Statements of Stockholders’ Equity for the Three and Six Months Ended June 30, 2024 and 2023	6

	Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2024 and 2023	8

	Notes to Interim Unaudited Condensed Consolidated Financial Statements	10

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	27

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	33

Item 4.	Controls and Procedures	34

Part II.	Other Information	34

Item 1A.	Risk Factors	34

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	36

Item 5.	Other Information	36

Item 6.	Exhibits	37

	Signatures	38

PART I. FINANCIAL INFORMATION

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

Certain statements contained in this Quarterly Report on this Form 10-Q (“Form 10-Q”) are not purely historical statements, discuss future expectations, contain projections of results of operations or financial condition, or state other forward-looking information. Those statements are subject to known and unknown risks, uncertainties, and other factors that could cause the actual results to differ materially from those contemplated by the statements. The “forward-looking” information is based on various factors and was derived using numerous assumptions. In some cases, you can identify these so-called forward-looking statements by words like “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of those words and other comparable words. You should be aware that those statements only reflect our predictions and are subject to risks and uncertainties. Actual events or results may differ substantially. Important factors that could cause our actual results to be materially different from the forward-looking statements include (but are not limited to) the following:

(1)the impact of the general economy and economic and political uncertainty on our business;

(2)risks associated with potential changes to U.S. and foreign laws, regulations, and policies;

(3)risks associated with the operation of our business generally, including:

a. client demand for our services and solutions;

b. effectively competing in a highly competitive market;

c. risks from international operations including fluctuations in exchange rates;

d. adapting to changes in technologies and offerings;

e. the ongoing transition of our executive leadership team;

f. obtaining favorable pricing to reflect services provided;

g. risk of loss of one or more significant software vendors;

h. maintaining a balance of our supply of skills and resources with client demand;

i. changes to immigration policies;

j. protecting our clients’ and our data and information;

k. changes to tax levels, audits, investigations, tax laws or their interpretation;

l. making appropriate estimates and assumptions in connection with preparing our consolidated financial statements; and

m. maintaining effective internal controls;

(4)risks associated with managing growth organically and through acquisitions;

(5)risks associated with servicing our debt, the potential impact on the value of our common stock from the conditional conversion features of our debt and the associated convertible note hedge transactions;

(6)legal liabilities, including intellectual property protection and infringement or the disclosure of personally identifiable information;

(7)the risks detailed from time to time within our filings with the Securities and Exchange Commission (the “SEC”);

(8)uncertainties associated with our proposed merger with an affiliate of BPEA Private Equity Fund VIII (“EQT Asia”);

(9)the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement entered into in connection with the proposed merger;

(10)risks related to disruption of management time from ongoing business operations due to the proposed merger;

(11)the risk that the conditions to the proposed merger may not be satisfied in a timely manner or at all;

(12)the risk of any unexpected costs or expenses resulting from the proposed merger;

(13)restrictions imposed on our business during the pendency of the proposed merger;

(14)the risk of any litigation relating to the proposed merger; and

(15)the risk that the proposed merger and its announcement could have an adverse effect on the ability of Perficient to retain and hire key personnel and to maintain relationships with customers, vendors, partners, employees, stockholders and other business relationships and on its operating results and business generally.

This discussion is not exhaustive, but is designed to highlight important factors that may impact our forward-looking statements. Because the factors referred to above, as well as the statements included under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 and this Form 10-Q, including documents incorporated by reference therein and herein, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statement made by us or on our behalf, you should not place undue reliance on any forward-looking statements.

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. We are under no duty to update any of the forward-looking statements after the date of this Form 10-Q to conform such statements to actual results.

All forward-looking statements, express or implied, included in this report and the documents we incorporate by reference that are attributable to Perficient, Inc. and its subsidiaries (collectively, “we,” “us,” “Perficient,” or the “Company”) are expressly qualified in their entirety by this cautionary statement. This cautionary statement should also be considered in connection with any subsequent written or oral forward-looking statements that the Company or any persons acting on our behalf may issue.

Item 1. Financial Statements

Perficient, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except share information)


	June 30, 2024 (unaudited)		December 31, 2023
Assets
Current assets:
Cash, cash equivalents and restricted cash	$	112,937	$	128,886
Accounts receivable, net	195,954		178,998
Prepaid expenses	6,219		5,638
Other current assets	23,298		12,431
Total current assets	338,408		325,953
Property and equipment, net	8,504		11,996
Operating lease right-of-use assets	22,521		21,786
Goodwill	608,774		581,387
Intangible assets, net	70,529		71,118
Other non-current assets	64,542		52,364
Total assets	$	1,113,278	$	1,064,604

Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	15,083	$	18,688
Other current liabilities	66,355		59,784
Total current liabilities	81,438		78,472
Long-term debt, net	398,018		396,874
Operating lease liabilities	17,420		16,446
Other non-current liabilities	45,600		42,189
Total liabilities	$	542,476	$	533,981
Stockholders’ equity:
Preferred stock (par value $0.001 per share; 8,000,000 authorized; no shares issued or outstanding as of June 30, 2024 and December 31, 2023)	$	—	$	—
Common stock (par value $0.001 per share; 100,000,000 authorized; 53,857,809 shares issued and 34,477,233 shares outstanding as of June 30, 2024; 53,465,127 shares issued and 34,174,200 shares outstanding as of December 31, 2023)	54		53
Additional paid-in capital	454,853		432,160
Accumulated other comprehensive loss	(12,504)		(5,461)
Treasury stock, at cost (19,380,576 shares as of June 30, 2024; 19,290,927 shares as of December 31, 2023)	(377,790)		(373,325)
Retained earnings	506,189		477,196
Total stockholders’ equity	570,802		530,623
Total liabilities and stockholders’ equity	$	1,113,278	$	1,064,604

See accompanying notes to interim unaudited condensed consolidated financial statements.

Perficient, Inc.

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except per share information)


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023

Revenues	$	222,817	$	231,105	$	438,121	$	462,513


Cost of revenues (exclusive of depreciation and amortization, shown separately below)
Cost of services	139,535		143,560		279,134		285,248
Stock compensation	2,535		2,608		5,042		5,132
Total cost of revenues	142,070		146,168		284,176		290,380

Selling, general and administrative	40,027		39,390		79,270		78,994
Stock compensation	3,731		4,787		13,654		9,103
Total selling, general and administrative	43,758		44,177		92,924		88,097



Depreciation	1,840		2,224		3,851		4,529
Amortization	4,862		5,523		9,748		11,340
Acquisition costs	132		(71)		1,050		8
Transaction expenses	6,688		—		7,163		—
Adjustment to fair value of contingent consideration	67		(2,701)		108		(4,727)
Income from operations	23,400		35,785		39,101		72,886

Net interest (income) expense	(729)		296		(1,496)		801

Net other (income) expense	(15)		387		(60)		462
Income before income taxes	24,144		35,102		40,657		71,623
Provision for income taxes	6,706		8,740		11,664		18,461

Net income	$	17,438	$	26,362	$	28,993	$	53,162

Basic net income per share	$	0.51	$	0.78	$	0.85	$	1.57
Diluted net income per share	$	0.49	$	0.73	$	0.81	$	1.48
Shares used in computing basic net income per share	34,353		33,988		34,251		33,951
Shares used in computing diluted net income per share	37,072		36,717		36,988		36,707

See accompanying notes to interim unaudited condensed consolidated financial statements.

Perficient, Inc.

Unaudited Condensed Consolidated Statements of Comprehensive Income

(in thousands)


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023

Net income	$	17,438	$	26,362	$	28,993	$	53,162
Other comprehensive (loss) income:

Foreign currency translation adjustment, net of tax	(6,168)		5,605		(7,043)		7,377
Comprehensive income	$	11,270	$	31,967	$	21,950	$	60,539

See accompanying notes to interim unaudited condensed consolidated financial statements.

Perficient, Inc.

Unaudited Condensed Consolidated Statements of Stockholders’ Equity

(in thousands)


		Three Months Ended				Six Months Ended
		June 30,				June 30,
		2024		2023		2024		2023


Common Stock
Beginning of period		$	54	$	53	$	53	$	53
	Stock compensation related to restricted stock vesting and retirement savings plan contributions	—		—		1		—
End of period		54		53		54		53
Additional Paid-in Capital
Beginning of period		448,855		410,959		432,160		403,866
	Proceeds from the sales of stock through the Employee Stock Purchase Plan	287		278		484		518
	Stock compensation related to restricted stock vesting and retirement savings plan contributions	5,711		6,886		18,217		13,739
	Issuance of stock in conjunction with acquisition including stock attributed to future compensation	—		—		3,992		—








End of period		454,853		418,123		454,853		418,123
Accumulated Other Comprehensive Loss
Beginning of period		(6,336)		(15,747)		(5,461)		(17,519)

	Foreign currency translation adjustment	(6,168)		5,605		(7,043)		7,377
End of period		(12,504)		(10,142)		(12,504)		(10,142)
Treasury Stock
Beginning of period		(377,594)		(362,149)		(373,325)		(354,536)
	Purchases of treasury stock and buyback of shares for taxes	(4)		(2,619)		(4,273)		(10,068)

	Stock reacquired for escrow claim	(192)		—		(192)		(164)
End of period		(377,790)		(364,768)		(377,790)		(364,768)
Retained Earnings
Beginning of period		488,751		405,063		477,196		378,263

	Net income	17,438		26,362		28,993		53,162
End of period		506,189		431,425		506,189		431,425
Total Stockholders’ Equity		$	570,802	$	474,691	$	570,802	$	474,691

See accompanying notes to interim unaudited condensed consolidated financial statements.








		Three Months Ended		Six Months Ended
		June 30,		June 30,
Common Stock, shares		2024	2023	2024	2023
Beginning of period		34,456	34,159	34,174	34,072
	Sales of stock through the Employee Stock Purchase Plan	6	4	9	8
	Stock compensation related to restricted stock vesting, retirement savings plan contributions and other	18	17	316	208
	Purchases of treasury stock, buyback of shares for taxes and other	—	(35)	(87)	(141)
	Issuance of stock in conjunction with acquisition including stock attributed to future compensation	—	—	68	—
	Stock reacquired for escrow claim	(3)	—	(3)	(2)
End of period		34,477	34,145	34,477	34,145

See accompanying notes to interim unaudited condensed consolidated financial statements.

Perficient, Inc.

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)


	Six Months Ended June 30,
	2024		2023
Operating Activities
Net income	$	28,993	$	53,162
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	3,851		4,529
Amortization	9,748		11,340

Deferred income taxes	(8,151)		(7,548)
Non-cash stock compensation and retirement savings plan contributions	18,129		13,829
Amortization of debt issuance costs	1,263		1,239
Adjustment to fair value of contingent consideration for purchase of businesses	108		(4,727)

Changes in operating assets and liabilities, net of business acquisitions:
Accounts receivable	(13,665)		16,168
Other assets	(14,741)		(1,061)
Accounts payable	(3,662)		(8,224)
Other liabilities	7,379		(13,596)
Net cash provided by operating activities	29,252		65,111

Investing Activities
Purchase of property and equipment	(2,568)		(3,200)
Capitalization of internally developed software costs	(672)		(607)
Purchase of businesses, net of cash acquired	(32,940)		254
Net cash used in investing activities	(36,180)		(3,553)

Financing Activities



Payment for credit facility financing fees	—		(750)


Payment of contingent consideration for purchase of business	(4,516)		(21,530)
Proceeds from the sale of stock through the Employee Stock Purchase Plan	484		518
Purchases of treasury stock	—		(4,991)
Remittance of taxes withheld as part of a net share settlement of restricted stock vesting	(4,273)		(5,077)
Net cash used in financing activities	(8,305)		(31,830)
Effect of exchange rate on cash, cash equivalents and restricted cash	(716)		613
Change in cash, cash equivalents and restricted cash	(15,949)		30,341
Cash, cash equivalents and restricted cash at beginning of period	128,886		30,130
Cash, cash equivalents and restricted cash at end of period	$	112,937	$	60,471

See accompanying notes to interim unaudited condensed consolidated financial statements.


	Six Months Ended June 30,
	2024		2023
Supplemental Disclosures:
Cash paid for income taxes	$	26,549	$	25,764
Cash paid for interest	$	650	$	416

Non-Cash Investing Activity:
Stock issued for purchase of businesses, net of stock reacquired for escrow claim	$	3,617	$	(164)
Liability incurred for purchase of property and equipment	$	—	$	190

See accompanying notes to interim unaudited condensed consolidated financial statements.

PERFICIENT, INC.

NOTES TO INTERIM UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

JUNE 30, 2024

1. Basis of Presentation

The accompanying interim unaudited condensed consolidated financial statements of Perficient, Inc. and its subsidiaries (collectively, the “Company”) have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and are presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) applicable to interim financial information. Accordingly, certain note disclosures have been condensed or omitted. In the opinion of management, the interim unaudited condensed consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments) necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the periods presented. These financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto filed with the SEC in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Certain reclassifications were made to prior year amounts to conform to the 2024 presentation.

2. Proposed Merger with Plano HoldCo Inc., an entity wholly-owned by funds affiliated with Baring Private Equity Asia

On May 5, 2024, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Plano HoldCo, Inc., a Delaware corporation (“Parent”), and Plano BidCo, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”). Parent and Merger Sub are affiliates of BPEA Private Equity Fund VIII (“EQT Asia”). Pursuant to the Merger Agreement, Merger Sub will be merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the “Merger” and, collectively with the other transactions contemplated by the Merger Agreement, the “Transactions”). Under the terms of the Merger Agreement, the Company’s stockholders will receive $76.00 in cash per share of Company common stock outstanding as of the closing of the Merger.

Consummation of the Merger is subject to various conditions, including, among others, customary conditions relating to the adoption of the Merger Agreement by the holders of a majority of the Company’s outstanding common stock, the expiration or termination of any applicable waiting periods under the Hart-Scott-Rodino Act (the “HSR Act”), conclusion of any review or investigation of the Transactions by the Committee on Foreign Investment in the United States, the receipt of certain foreign regulatory approvals and other customary conditions for a transaction of this type, such as the absence of any legal restraint prohibiting the consummation of the Transactions and the absence of any Company Material Adverse Effect (as defined in the Merger Agreement). Consummation of the Merger is not subject to any financing condition, and is expected to occur by the end of 2024.

The HSR Act waiting period expired on July 1, 2024. On July 30, 2024, at a special meeting of stockholders, the stockholders of the Company approved and adopted the Merger Agreement. The closing of the Merger remains subject to the satisfaction or waiver of the remaining conditions to the Merger set forth in the Merger Agreement, including, among other things, the receipt of approvals required by relevant governmental authorities under foreign investment laws in Romania, and the receipt of the CFIUS Approval without the imposition of a Burdensome Condition (as defined in the Merger Agreement).

The Company expects to incur significant costs, expenses and fees for professional services and other transaction costs in connection with the Merger Agreement. If the Merger Agreement is terminated under certain circumstances, the Company will be required to pay Parent a termination fee of $81.3 million, or Parent will be required to pay the Company a termination fee of $162.6 million as applicable. See Note 17, Commitments and Contingencies, for information regarding litigation filed in respect of the Merger.

3. Summary of Significant Accounting Policies

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates, and such differences could be material to the financial statements.

There have been no changes to significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, 2023 that have had a material impact on the Company’s condensed consolidated financial statements and related notes.

4. Recent Accounting Pronouncements

In November 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280) Improvements To Reportable Segment Disclosures, which requires additional disclosures about a public entity’s reportable segments and addresses requests from investors and other allocators of capital for additional, more detailed information about a reportable segment’s expenses. The Company will adopt this ASU retrospectively for the annual period beginning on January 1, 2024 and for interim periods beginning on January 1, 2025.

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) Improvements To Income Tax Disclosures, which requires additional disclosures of income tax components that affect the rate reconciliation and income taxes paid, broken out by the applicable taxing jurisdictions. The Company expects to adopt this ASU prospectively for the annual period beginning on January 1, 2025.

5. Revenue

The Company’s revenues consist of services and software and hardware sales. In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, revenues are recognized when control of services or goods are transferred to clients, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services or goods.

Services Revenues

Services revenues are primarily comprised of professional services that include developing, implementing, automating and extending business processes, technology infrastructure, and software applications. The Company’s professional services span multiple industries, platforms and solutions; however, the Company has remained relatively diversified and does not believe that it has significant revenue concentration within any single industry, platform or solution.

Professional services revenues are recognized over time as services are rendered. Most projects are performed on a time and materials basis, while a portion of revenues is derived from projects performed on a fixed fee or fixed fee percent complete basis. For time and material contracts, revenues are generally recognized and invoiced by multiplying the number of hours expended in the performance of the contract by the hourly rates. For fixed fee contracts, revenues are generally recognized and invoiced by multiplying the fixed rate per time period established in the contract by the number of time periods elapsed. For fixed fee percent complete contracts, revenues are generally recognized using an input method based on the ratio of hours expended to total estimated hours, and the client is invoiced according to the agreed-upon schedule detailing the amount and timing of payments in the contract. In conjunction with services provided, we occasionally receive referral fees under partner programs. These referral fees are recognized at a point in time when earned and recorded within services revenues.

Clients are typically billed monthly for services provided during that month but can be billed on a more or less frequent basis as determined by the contract. If the time is worked and approved at the end of a fiscal period and the invoice has not yet been sent to the client, the amount is recorded as revenue once the Company verifies all other revenue recognition criteria have been met, and the amount is classified as a receivable as the right to consideration is unconditional at that point. Amounts invoiced in excess of revenues recognized are contract liabilities, which are classified as deferred revenues in the Unaudited Condensed Consolidated Balance Sheet. The term between invoicing and payment due date is not significant. Contracts for professional services provide for a general right, to the client or the Company, to cancel or terminate the contract within a given period of time (generally 10 to 30 days’ notice is required). The client is responsible for any time and expenses incurred up to the date of cancellation or termination of the contract. Certain contracts may include volume discounts or holdbacks, which are accounted for as variable consideration, but are not typically significant. The Company estimates variable consideration based on historical experience and forecasted sales and includes the variable consideration in the transaction price.

On many professional service projects, the Company is also reimbursed for out-of-pocket expenses including travel and other project-related expenses. These reimbursements are included as a component of the transaction price of the respective professional services contract and are invoiced as the expenses are incurred. The Company structures its professional services arrangements to recover the cost of reimbursable expenses without a markup.

Software and Hardware Revenues

Software and hardware revenues are comprised of third-party software and hardware resales, in which the Company is considered the agent, and sales of internally developed software, in which the Company is considered the principal. Third-party software and hardware revenues are recognized and invoiced when the Company fulfills its obligation to arrange the sale, which occurs when the purchase order with the vendor is executed and the customer has access to the software or the hardware has been shipped to the customer. Internally developed software revenues are recognized and invoiced when control is transferred to the customer, which occurs when the software has been made available to the customer and the license term has commenced. Revenues from third-party software and hardware sales are recorded on a net basis, while revenues from internally developed software sales are recorded on a gross basis. There are no significant cancellation or termination-type provisions for the Company’s software and hardware sales, and the term between invoicing and payment due date is not significant.

Revenues are presented net of taxes assessed by governmental authorities. Sales taxes are generally collected and subsequently remitted on all software and hardware sales and certain services transactions as appropriate.

Arrangements with Multiple Performance Obligations

Arrangements with clients may contain multiple promises such as delivery of software, hardware, professional services or post-contract support services. These promises are accounted for as separate performance obligations if they are distinct. For arrangements with clients that contain multiple performance obligations, the transaction price is allocated to the separate performance obligations based on estimated relative standalone selling price, which is estimated by the expected cost plus a margin approach, taking into consideration market conditions and competitive factors. Because contracts that contain multiple performance obligations are typically short term due to the contract cancellation provisions, the allocation of the transaction price to the separate performance obligations is not considered a significant estimate.

Contract Costs

In accordance with the terms of the Company’s sales commission plan, commissions are not earned until the related revenue is recognized. Therefore, sales commissions are expensed as they are earned. Certain sales incentives are accrued based on achievement of specified bookings goals. For these incentives, the Company applies the practical expedient that allows the Company to expense the incentives as incurred because the amortization period would have been one year or less.

Deferred Revenue

The Company’s deferred revenue balance as of June 30, 2024 and December 31, 2023 was $1.6 million and $5.5 million, respectively. Substantially all of the December 31, 2023 deferred revenue balance was recognized in revenue during the six months ended June 30, 2024.

Transaction Price Allocated to Remaining Performance Obligations

Due to the ability of the client or the Company to cancel or terminate the contract within a given period of time (generally 10 to 30 days’ notice is required), the majority of the Company’s contracts have a term of less than one year. The Company does not disclose the value of unsatisfied performance obligations for contracts with an original maturity date of one year or less or time and materials contracts for which the Company has the right to invoice for services performed. Revenue related to unsatisfied performance obligations for remaining contracts as of June 30, 2024 was immaterial.

Disaggregation of Revenue

The following tables present revenue disaggregated by revenue source and pattern of revenue recognition (in millions):


	Three Months Ended June 30,
	2024						2023
	Over Time		Point In Time		Total Revenues		Over Time		Point In Time		Total Revenues
Time and materials contracts	$	160.1	$	—	$	160.1	$	170.6	$	—	$	170.6
Fixed fee percent complete contracts	13.9		—		13.9		16.2		—		16.2
Fixed fee contracts	45.5		—		45.5		41.2		—		41.2
Reimbursable expenses	2.9		—		2.9		2.1		—		2.1
Total professional services fees	222.4		—		222.4		230.1		—		230.1
Other services revenue*	—		0.1		0.1		—		0.6		0.6
Total services	222.4		0.1		222.5		230.1		0.6		230.7
Software and hardware	—		0.3		0.3		—		0.4		0.4
Total revenues	$	222.4	$	0.4	$	222.8	$	230.1	$	1.0	$	231.1

*Other services revenue primarily consists of partner referral fees. These referral fees are recognized at a point in time when earned and recorded within services revenues.


	Six Months Ended June 30,
	2024						2023
	Over Time		Point In Time		Total Revenues		Over Time		Point In Time		Total Revenues
Time and materials contracts	$	314.3	$	—	$	314.3	$	346.1	$	—	$	346.1
Fixed fee percent complete contracts	28.7		—		28.7		31.0		—		31.0
Fixed fee contracts	87.5		—		87.5		78.9		—		78.9
Reimbursable expenses	6.5		—		6.5		4.6		—		4.6
Total professional services fees	437.0		—		437.0		460.6		—		460.6
Other services revenue*	—		0.4		0.4		—		1.0		1.0
Total services	437.0		0.4		437.4		460.6		1.0		461.6
Software and hardware	—		0.7		0.7		—		0.9		0.9
Total revenues	$	437.0	$	1.1	$	438.1	$	460.6	$	1.9	$	462.5

*Other services revenue primarily consists of partner referral fees. These referral fees are recognized at a point in time when earned and recorded within services revenues.

The following table presents revenue disaggregated by geographic area, as determined by the billing address of customers (in millions):


	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
United States	$	211.1	$	223.0	$	416.7	$	446.5
Other countries	11.7		8.1		21.4		16.0
Total revenues	$	222.8	$	231.1	$	438.1	$	462.5

6. Stock-Based Compensation

Stock-based compensation is accounted for in accordance with ASC Topic 718, Compensation – Stock Compensation. Under this guidance, the Company recognizes share-based compensation ratably using the straight-line attribution method over the requisite service period, which is generally three years. The fair value of restricted stock awards is based on the value of the Company’s common stock on the date of the grant.

The Company’s Third Amended and Restated 2012 Long Term Incentive Plan (as amended, the “Incentive Plan”) allows for the granting of various types of stock awards, not to exceed a total of 8.5 million shares, to eligible individuals. The Compensation Committee of the Board of Directors administers the Incentive Plan and determines the terms of all stock awards made under the Incentive Plan. As of June 30, 2024, there were 1.9 million shares of common stock available for issuance under the Incentive Plan.

Stock-based compensation cost recognized for the three and six months ended June 30, 2024 was $6.3 million and $18.7 million, respectively, which included $1.2 million and $2.2 million, respectively, of expense for retirement savings plan contributions. The associated current and future income tax benefit recognized was $1.7 million and $5.4 million for the three and six months ended June 30, 2024, respectively. Stock-based compensation cost recognized for the three and six months ended June 30, 2023 was $7.4 million and $14.2 million, respectively, which included $1.3 million and $2.4 million, respectively, of expense for retirement savings plan contributions. The associated current and future income tax benefit recognized was $1.9 million and $3.7 million, respectively, for the three and six months ended June 30, 2023.

On February 23, 2024, Jeffrey S. Davis resigned his employee position as Executive Chairman of the Company, effective as of March 1, 2024. Mr. Davis is continuing as the non-executive Chairman of the Board of Directors. In connection with Mr. Davis’s resignation, the Board of Directors approved an amendment to certain existing restricted stock award agreements. Due to the resignation of Mr. Davis as Executive Chairman of the Company and the related restricted stock award amendment, the incremental share based compensation expense recorded during the six months ended June 30, 2024 was approximately $5.6 million.

Restricted Stock Awards (“RSAs”)

Restricted stock activity for the six months ended June 30, 2024 was as follows (shares in thousands):


	RSAs (Shares)	Weighted-Average Grant Date Fair Value
Restricted stock awards outstanding at December 31, 2023	714	$	70.80
Awards granted	195	69.00
Awards vested	(197)	73.73
Awards forfeited	(36)	66.25
Restricted stock awards outstanding at June 30, 2024	676	$	69.68

As of June 30, 2024, there was $31.2 million of total unrecognized compensation cost related to non-vested RSAs with a weighted-average remaining life of two years.

Performance Stock Awards (“PSAs”)

In connection with Thomas J. Hogan’s promotion to Chief Executive Officer effective October 1, 2023, the Company granted a PSA of 10,842 shares to Mr. Hogan under the Incentive Plan. The actual number of shares subject to the PSA that will be eligible to vest is based on the achievement of a relative total shareholder return (“TSR”) target as compared to the TSR realized by each of the companies comprising the Nasdaq Composite Index over a three-year period. The grant date fair value of $80.90 per share was based on a Monte Carlo simulation model as of the date of the award. PSA related stock-based compensation cost recognized for the three and six months ended June 30, 2024 was $0.1 million. As of June 30, 2024, there was $0.6 million of total unrecognized compensation cost related to unvested PSAs, expected to be recognized over a period of three years.

7. Net Income per Share

The following table presents the calculation of basic and diluted net income per share (in thousands, except per share information):


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Net income, basic	$	17,438	$	26,362	$	28,993	$	53,162
Add back interest expense on convertible notes, net of tax	551		573		1,088		1,133
Net income, diluted	$	17,989	$	26,935	$	30,081	$	54,295

Basic:
Weighted-average shares of common stock outstanding	34,353		33,988		34,251		33,951
Shares used in computing basic net income per share	34,353		33,988		34,251		33,951
Effect of dilutive securities:
Restricted stock and performance stock awards subject to vesting	173		133		175		144
Shares issuable for acquisition consideration (1)	116		166		132		182
Shares issuable for conversion of convertible senior notes	2,430		2,430		2,430		2,430

Shares used in computing diluted net income per share	37,072		36,717		36,988		36,707

Basic net income per share	$	0.51	$	0.78	$	0.85	$	1.57
Diluted net income per share	$	0.49	$	0.73	$	0.81	$	1.48

(1)For the three and six months ended June 30, 2024, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with Zeon Solutions Incorporated and certain related entities (collectively, “Zeon”); (ii) the Purchase Agreement with Talos LLC, Talos Digital LLC, Talos Digital SAS and TCOMM SAS (collectively, “Talos”); (iii) the Stock Purchase Agreement with the shareholders of Izmul S.A. (“Overactive”); (iv) the Purchase Agreement with the shareholders of Ameex Technologies Corporation (“Ameex”); and (v) the Purchase Agreement with the shareholders of SMEDIX, Inc. (“SMEDIX”), as part of the consideration. For the three and six months ended June 30, 2023, this represents the shares held in escrow pursuant to: (i) the Asset Purchase Agreement with Zeon; (ii) the Asset Purchase Agreement with Catalyst Networks, Inc. (“Brainjocks”); (iii) the Stock Purchase Agreement with the shareholders of Productora de Software S.A.S. (“PSL”); (iv) the Purchase Agreement with Talos; (v) the Stock Purchase Agreement with the shareholders of Overactive; (vi) the Stock Purchase Agreement with the shareholders of Inflection Point Systems, Inc.; and (vii) the Purchase Agreement with the shareholders of Ameex, as part of the consideration.

The number of anti-dilutive securities not included in the calculation of diluted net income per share were as follows (in thousands):


	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2024	2023	2024	2023
Restricted stock and performance stock awards subject to vesting	121	144	115	210

Warrants related to the issuance of convertible senior notes	2,431	2,431	2,431	2,431
Total anti-dilutive securities	2,552	2,575	2,546	2,641

See Note 12, Long-term Debt for further information on the convertible senior notes and warrants related to the issuance of convertible notes.

The Company’s Board of Directors authorized the repurchase of up to $375.0 million of Company common stock through a stock repurchase program expiring December 31, 2024. The program could be suspended or discontinued at any time, based on market, economic, or business conditions. The timing and amount of repurchase transactions will be determined by management based on its evaluation of market conditions, share price, and other factors. Since the program’s inception on August 11, 2008, the Company has repurchased approximately $291.1 million (16.5 million shares) of outstanding common stock through June 30, 2024.

8. Balance Sheet Components


	June 30, 2024 (unaudited)		December 31, 2023
Accounts receivable:	(in millions)
Billed accounts receivable, net	$	96.1	$	119.9
Unbilled revenues, net	99.9		59.1
Total	$	196.0	$	179.0


Other current assets:
Miscellaneous receivables	$	3.6	$	3.1
Contractual commitment asset	5.1		3.0
Income tax receivable	10.5		2.7
Other current assets	4.1		3.6
Total	$	23.3	$	12.4


Property and equipment:
Computer hardware (useful life of 3 years)	$	25.1	$	26.7
Software (useful life of 1 to 7 years)	8.7		9.2
Furniture and fixtures (useful life of 5 years)	4.3		4.5
Leasehold improvements (useful life of 5 years)	7.6		7.8
Less: Accumulated depreciation	(37.2)		(36.2)
Total	$	8.5	$	12.0



Other non-current assets:
Non-current unbilled revenue	$	1.4	$	2.2
Company owned life insurance asset	14.3		12.6
Long term deposits	1.9		1.8
Credit facility deferred financing fees, net	0.9		1.0
Other non-current assets	17.1		13.2
Deferred income taxes	28.9		21.6
Total	$	64.5	$	52.4



Other current liabilities:
Estimated fair value of contingent consideration liability (Note 10)	$	6.5	$	4.5
Accrued variable compensation	22.1		15.9
Current operating lease liabilities	6.6		7.0
Payroll related costs	12.1		11.1
Deferred revenues	1.6		5.5
Income tax payable	1.3		1.5
Other current liabilities	7.1		4.8
Accrued medical claims expense	2.3		3.2
Professional fees	3.3		1.3
Accrued IT expenses	3.5		5.0
Total	$	66.4	$	59.8


	June 30, 2024 (unaudited)		December 31, 2023
Other non-current liabilities:	(in millions)
Deferred income taxes	$	4.8	$	5.9
Reserve for uncertain tax positions	19.0		17.7
Deferred compensation liability	12.5		11.0
Other non-current liabilities	7.6		5.0
Non-current software accrual	1.7		2.6
Total	$	45.6	$	42.2

9. Allowance for Credit Losses

In accordance with ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, the Company evaluates its allowance based on expected losses rather than incurred losses, which is known as the current expected credit loss model. The allowance is determined using the loss rate approach and is measured on a collective (pool) basis when similar risk characteristics exist. Where financial instruments do not share risk characteristics, they are evaluated on an individual basis. The allowance is based on relevant available information, from internal and external sources, relating to past events, current conditions, and reasonable and supportable forecasts.

Activity in the allowance for credit losses is summarized as follows (in millions):


	Six Months Ended June 30,
	2024		2023


Opening balance at January 1	$	2.5	$	5.8
Charges to expense, net of recoveries	0.2		(0.3)
Other (1)	(0.2)		(2.0)
Balance at June 30	$	2.5	$	3.5

(1) Other is primarily related to uncollected balances written off and currency translation adjustments.

10. Business Combinations

2024 Acquisition

On January 16, 2024, the Company acquired all of the outstanding capital stock of SMEDIX. SEMDIX is a healthcare software engineering firm headquartered in San Diego, California, with offshore operations located in Cluj-Napoca, Romania. The acquisition of SMEDIX continued to strengthen our healthcare industry digital capabilities, enhance our global delivery capacity, and expand further within Eastern Europe. SMEDIX added more than 175 professionals and strategic client relationships focused in the biomedical and healthcare industry. The Company’s total allocable purchase price consideration was $43.3 million, net of cash acquired. The Company incurred approximately $1.7 million in transaction costs, which were expensed when incurred. The amount of goodwill deductible for tax purposes is $33.4 million.

The acquisition date fair value of the consideration transferred for SMEDIX consisted of the following (in millions):


	SMEDIX
Cash, net of cash acquired	$	32.9
Company common stock issued at closing	3.8
Contingent consideration (1)	6.4		(2)
Net working capital adjustment due to the seller(s)	0.2
Total allocable purchase price consideration	$	43.3

(1)Represents the initial fair value estimate of additional revenue and earnings-based contingent consideration, which may be realized by the sellers 12 months after the closing date of the acquisition.

(2)The maximum cash payout that may be realized by the sellers in the SMEDIX acquisition is $14.4 million. As of June 30, 2024, the fair value of the contingent consideration was $6.5 million.

The Company has estimated the preliminary allocation of the total purchase price consideration between tangible assets, identified intangible assets, liabilities, and goodwill as follows (in millions):


	SMEDIX
Acquired tangible assets	$	5.1
Identified intangible assets	8.9
Liabilities assumed	(3.2)
Goodwill	32.5
Total allocable purchase price consideration	$	43.3

The following table presents details of the intangible assets acquired during the three months ended June 30, 2024.

Weighted Average Useful Life

Estimated Useful Life

SMEDIX

Customer relationships

6 years

7.0

Customer backlog

1 year

1.7

Non-compete agreements

5 years

0.1

Trade name

1 year

0.1

Total acquired intangible assets

8.9

The above purchase price accounting estimates for SMEDIX are pending finalization of certain acquired tangible and intangible assets, contingent consideration valuation, and a net working capital settlement that is subject to final adjustment as the Company evaluates information during the measurement period.

Pro-forma Results of Operations

Pro-forma results of operations have not been presented for SMEDIX because the effect of the acquisition on the Company's condensed consolidated financial statements was not material.

11. Goodwill and Intangible Assets

Goodwill represents the excess purchase price over the fair value of net assets acquired, or net liabilities assumed, in a business combination. In accordance with ASC Topic 350, Intangibles – Goodwill and Other, the Company performs an annual impairment review in the fourth quarter and more frequently if events or changes in circumstances indicate that goodwill might be impaired. There was no indication that goodwill became impaired for the three and six months ended June 30, 2024.

Other intangible assets include customer relationships, non-compete arrangements, trade names, customer backlog, and developed software, which are being amortized over the assets’ estimated useful lives using the straight-line method. Estimated useful lives range from less than one year to ten years. Amortization of customer relationships, non-compete arrangements, trade names, customer backlog, and developed software is considered an operating expense and is included in “Amortization” in the accompanying Unaudited Condensed Consolidated Statements of Operations. The Company periodically reviews the estimated useful lives of its identifiable intangible assets, taking into consideration any events or circumstances that might result in a lack of recoverability or revised useful life. There was no indication that other intangible assets became impaired for the three and six months ended June 30, 2024.

Goodwill

The changes in the carrying amount of goodwill for the six months ended June 30, 2024 are as follows (in millions):


Balance at December 31, 2023	$	581.4
Purchase price allocation for SMEDIX	32.5
Effect of foreign currency translation adjustments	(5.1)
Balance at June 30, 2024	$	608.8

Intangible Assets with Definite Lives

The following table presents a summary of the Company’s intangible assets that are subject to amortization (in millions):


	June 30, 2024 (unaudited)						December 31, 2023
	Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts		Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts
Customer relationships	$	114.2	$	(46.7)	$	67.5	$	116.1	$	(47.3)	$	68.8
Non-compete agreements	1.2		(0.7)		0.5		1.1		(0.6)		0.5
Customer backlog	1.7		(0.8)		0.9		—		—		—
Trade name	0.9		(0.8)		0.1		0.8		(0.8)		—
Developed software	9.1		(7.6)		1.5		8.5		(6.7)		1.8
Total	$	127.1	$	(56.6)	$	70.5	$	126.5	$	(55.4)	$	71.1

The estimated useful lives of identifiable intangible assets are as follows:


Customer relationships			5 - 10 years
Non-compete agreements			4 - 5 years
Customer backlog			1 year
Trade name			1 year
Developed software			1 - 7 years

Estimated annual amortization expense for the next five years ended December 31 and thereafter is as follows (in millions):


2024 remaining	$	9.0
2025	$	13.4
2026	$	10.9
2027	$	8.5
2028	$	7.4
Thereafter	$	21.3

12. Long-term Debt

Revolving Credit Facility

On March 29, 2023, the Company amended and restated its existing credit agreement by entering into a Second Amended and Restated Credit Agreement (the “2023 Credit Agreement”) with Wells Fargo Bank, National Association, as administrative agent and the other lenders parties thereto. The 2023 Credit Agreement provides for revolving credit borrowings up to a maximum principal amount of $300.0 million, subject to a commitment increase of $75.0 million. All outstanding amounts owed under the 2023 Credit Agreement become due and payable no later than the final maturity date of March 29, 2028. As of June 30, 2024, there was no outstanding balance under the 2023 Credit Agreement. The Company incurred $0.8 million of additional deferred financing fees during the six months ended June 30, 2023.

The 2023 Credit Agreement also allows for the issuance of letters of credit in the aggregate amount of up to $10.0 million at any one time; outstanding letters of credit reduce the credit available for revolving credit borrowings. As of June 30, 2024, there were no outstanding letters of credit. Substantially all of the Company’s assets are pledged to secure the credit facility.

Borrowings under the 2023 Credit Agreement bear interest at the Company’s option of the prime rate (8.50% on June 30, 2024) plus a margin ranging from 0.00% to 1.00% or one month Secured Overnight Financing Rate (“SOFR”) (5.33% on June 30, 2024) plus a margin ranging from 1.00% to 2.00%. The Company incurs an annual commitment fee of 0.15% to 0.20% on the unused portion of the line of credit. The additional margin amount and annual commitment fee are dependent on the level of outstanding borrowings. As of June 30, 2024, the Company had $300.0 million of unused borrowing capacity.

The Company is required to comply with various financial covenants under the 2023 Credit Agreement. At June 30, 2024, the Company was in compliance with all covenants under the 2023 Credit Agreement.

Convertible Senior Notes due 2026

On November 9, 2021, the Company issued $380.0 million aggregate principal amount of 0.125% Convertible Senior Notes Due 2026 (the “2026 Notes”) in a private placement to qualified institutional buyers pursuant to an exemption from registration provided by Section 4(a)(2) and Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The 2026 Notes bear interest at a rate of 0.125% per year. Interest is payable in cash on May 15 and November 15 of each year, with the first payment made on May 15, 2022. The 2026 Notes mature on November 15, 2026 unless earlier converted, redeemed or repurchased in accordance with their terms prior to such date. The initial conversion rate is 5.2100 shares of the Company’s common stock per $1,000 principal amount of 2026 Notes, which is equivalent to an initial conversion price of approximately $191.94 per share of common stock. After consideration of the 2026 Notes Hedges and 2026 Notes Warrants (as defined and described below), the conversion rate is effectively hedged to a price of $295.29 per share of common stock. The conversion rate, and thus the conversion price, may be adjusted under certain circumstances as described in the indenture governing the 2026 Notes (the “2026 Indenture”). The Company may settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election, based on the applicable conversion rate(s). If a “make-whole fundamental change” (as defined in the 2026 Indenture) occurs, then the Company will in certain circumstances increase the conversion rate for a specified period of time. The Company’s intent is to settle the principal amount of the 2026 Notes in cash upon conversion.

At the effective time of the Merger, the Company (the surviving entity following the Merger) will be required to offer to repurchase the 2026 Notes at a repurchase price equal to 100% of the principal amount thereof, plus accrued and unpaid interest. Holders may also elect to surrender their Notes for conversion upon effectiveness of the Merger in accordance with the terms of the 2026 Indenture.

Convertible Senior Notes due 2025

On August 14, 2020, the Company issued $230.0 million aggregate principal amount of 1.250% Convertible Senior Notes Due 2025 (the “2025 Notes”) in a private placement to qualified institutional purchasers pursuant to an exemption from registration provided by Section 4(a)(2) and Rule 144A under the Securities Act. The 2025 Notes bear interest at a rate of 1.250% per year. Interest is payable in cash on February 1 and August 1 of each year. The 2025 Notes mature on August 1, 2025 unless earlier converted, redeemed or repurchased in accordance with their terms prior to such date. The initial conversion rate is 19.3538 shares of the Company’s common stock per $1,000 principal amount of 2025 Notes, which is equivalent to an initial conversion price of approximately $51.67 per share of common stock. After consideration of the 2025 Notes Hedges and 2025 Notes Warrants (as defined and described below), the conversion rate is effectively hedged to a price of $81.05 per share of common stock. The conversion rate, and thus the conversion price, may be adjusted under certain circumstances as described in the indenture governing the 2025 Notes (the “2025 Indenture”). The Company may settle conversions by paying or delivering, as applicable, cash, shares of its common stock or a combination of cash and shares of its common stock, at the Company’s election, based on the applicable conversion rate(s). If a “make-whole fundamental change” (as defined in the 2025 Indenture) occurs, then the Company will in certain circumstances increase the conversion rate for a specified period of time. The Company’s intent is to settle the principal amount of the 2025 Notes in cash upon conversion.

At the effective time of the Merger, the Company (the surviving entity following the Merger) will be required to offer to repurchase the 2025 Notes at a repurchase price equal to 100% of the principal amount thereof, plus accrued and unpaid interest. Holders may also elect to surrender their Notes for conversion upon effectiveness of the Merger in accordance with the terms of the 2025 Indenture.

Other Terms of the Notes

The 2025 Notes and 2026 Notes may be converted at the holder’s option prior to the close of business on the business day immediately preceding August 1, 2025 for the 2025 Notes and November 15, 2026 for the 2026 Notes, but only under the following circumstances:

•during any calendar quarter commencing after the calendar quarter ending on September 30, 2020 for the 2025 Notes and December 31, 2021 for the 2026 Notes, if the last reported sale price per share of the Company’s common stock exceeds 130% of the applicable conversion price for each of at least 20 trading days during the 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter;

•during the five consecutive business days immediately after any 10 consecutive trading day period (such 10 consecutive trading day period, the “measurement period”) in which the trading price per $1,000 principal amount of notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price per share of the Company’s common stock on such trading day and the applicable conversion rate on such trading day;

•upon the occurrence of certain corporate events or distributions on the Company’s common stock described in the 2025 Indenture and 2026 Indenture; and

•at any time from, and including, February 3, 2025 for 2025 Notes and May 15, 2026 for 2026 Notes, until the close of business on the second scheduled trading day immediately before the maturity date for the 2025 Notes and 2026 Notes.

The Company may not redeem the 2025 Notes and 2026 Notes at its option before maturity. If a “fundamental change” (as defined in the 2025 Indenture and 2026 Indenture) occurs, then, except as described in the 2025 Indenture and 2026 Indenture, noteholders may require the Company to repurchase their 2025 Notes and 2026 Notes at a cash repurchase price equal to the principal amount of the 2025 Notes and 2026 Notes to be repurchased, plus accrued and unpaid interest, if any.

Upon delivery of a notice of a fundamental change, such as the Merger, holders of the 2025 Notes and 2026 Notes may surrender all or any portion of their 2025 Notes and 2026 Notes for conversion at any time after the effective date of the Merger or such other transaction until the related fundamental change repurchase date of the 2025 Notes and the 2026 Notes. In addition, if specific corporate events, including the Merger, occur prior to the applicable maturity date of the 2025 Notes or the 2026 Notes, the Company will be required to increase the conversion rate for holders who elect to convert their 2025 Notes or 2026 Notes in connection with such corporate events. If a fundamental change, including the Merger, occurs prior to the applicable maturity date, holders of the 2025 Notes or 2026 Notes, as applicable, will also have the right to require the Company to repurchase all or a portion of their 2025 Notes or 2026 Notes for cash at a repurchase price equal to 100% of the principal amount thereof, plus any accrued and unpaid interest to, but excluding, the repurchase date of the 2025 Notes or 2026 Notes.

During the three months ended June 30, 2024, the conditional conversion features of the 2025 Notes were triggered as the last reported sale price of the Company's common stock was greater than or equal to 130% of the conversion price for at least 20 trading days in the period of 30 consecutive trading days ended on June 28, 2024 (the last trading day of the fiscal quarter). Therefore, the 2025 Notes are currently convertible, in whole or in part, at the option of the holder during the quarter ending September 30, 2024. Whether the 2025 Notes will be convertible following such period will depend on the continued satisfaction of this condition or another conversion condition in the future. Since the Company has the election of repaying the 2025 Notes in cash, shares of the Company’s common stock, or a combination of both, the Company continued to classify the 2025 Notes as long-term debt on the Condensed Consolidated Balance Sheet as of June 30, 2024 (unaudited). As of the date of this filing, none of the current holders of the 2025 Notes as of June 30, 2024 have submitted requests for conversion. As of June 30, 2024, none of the conditions permitting holders to convert their 2026 Notes has been satisfied and no shares of the Company’s common stock had been issued in connection with any conversions of the 2026 Notes during the three and six months ended June 30, 2024. Based on the closing price of the Company's common stock of $74.79 per share on June 30, 2024, the conversion value of the 2026 Notes was less than the principal amount of the 2026 Notes outstanding on a per note basis, and the conversion value of the 2025 Notes was greater than the principal amount of the 2025 Notes outstanding on a per note basis.

The 2025 Notes and 2026 Notes consisted of the following (in millions):


	June 30, 2024 (unaudited)
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3
Less: Unamortized debt issuance costs	(5.1)		(0.2)
Net carrying amount	$	374.9	$	23.1


	December 31, 2023
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3

Less: Unamortized debt issuance costs	(6.1)		(0.3)
Net carrying amount	$	373.9	$	23.0

Interest expense for the three and six months ended June 30, 2024 and 2023 related to the 2026 Notes and 2025 Notes consisted of the following (in millions):

2026 Notes


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Coupon interest	$	0.1	$	0.1	$	0.2	$	0.2

Amortization of debt issuance costs	0.6		0.6		1.1		1.0
Total interest expense recognized	$	0.7	$	0.7	$	1.3	$	1.2

2025 Notes


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Coupon interest	$	0.1	$	0.1	$	0.1	$	0.1

Amortization of debt issuance costs	—		—		0.1		0.1
Total interest expense recognized	$	0.1	$	0.1	$	0.2	$	0.2

Convertible Notes Hedges

In connection with the issuance of the 2026 Notes and 2025 Notes, the Company entered into privately negotiated convertible note hedge transactions (the “2026 Notes Hedges” and the “2025 Notes Hedges”), and together, the “Notes Hedges”) with certain of the initial purchasers or their respective affiliates and/or other financial institutions (the “Option Counterparties”). As of June 30, 2024, the 2026 Notes Hedges provide the Company with the option to acquire, on a net settlement basis, approximately 2.0 million shares of common stock at a strike price of $191.94, which is equal to the number of shares of common stock that notionally underlie the 2026 Notes and correspond to the conversion price of the 2026 Notes. As of June 30, 2024, the 2025 Notes Hedges provided the Company with the option to acquire, on a net settlement basis, approximately 0.5 million shares of common stock at a strike price of $51.67, which is equal to the number of shares of common stock that notionally underlie the 2025 Notes and correspond to the conversion price of the 2025 Notes. If the Company elects cash settlement and exercises the Notes Hedges, the aggregate amount of cash received from the Option Counterparties will cover the aggregate amount of cash that the Company would be required to pay to the holders of the Notes, less the principal amount thereof. The Notes Hedges do not meet the criteria for separate accounting as a derivative as they are indexed to the Company’s stock and are accounted for as freestanding financial instruments.

Convertible Notes Warrants

In connection with the issuance of the 2026 Notes and 2025 Notes, the Company also sold net-share-settled warrants (the “2026 Notes Warrants” and the “2025 Notes Warrants,” respectively, and together, the “Notes Warrants”) in privately negotiated transactions with the Option Counterparties. The strike price of the 2026 Notes Warrants and 2025 Notes Warrants was approximately $295.29 and $81.05 per share, respectively, and is subject to certain adjustments under the terms of their respective Notes Warrants. As a result of the 2026 Notes Warrants and 2025 Notes Warrants and related transactions, the Company is required to recognize incremental dilution of earnings per share to the extent the average share price for any fiscal quarter is over $295.29 for the 2026 Notes Warrants and $81.05 for the 2025 Notes Warrants. The 2026 Notes Warrants and the 2025 Notes Warrants expire over a period of 80 trading days commencing on February 15, 2027 and over a period of 100 trading days commencing on November 1, 2025, respectively, and may be settled in net shares of common stock or net cash at the Company’s election. As of June 30, 2024, 2.0 million warrant shares and 0.5 million warrant shares were outstanding for the 2026 Notes Warrants and 2025 Notes Warrants, respectively.

13. Income Taxes

The Company's effective tax rate was 27.8% and 28.7% for the three and six months ended June 30, 2024, respectively. The effective tax rates for the three and six months ended June 30, 2024 were higher than the U.S. statutory rate of 21.0% primarily due to state taxes, Internal Revenue Code Section 162(m) compensation limitations and foreign operations, partially offset by tax benefits for research credits.

The Company’s effective tax rate was 24.9% and 25.8% for the three and six months ended June 30, 2023, respectively. The effective tax rates for the three and six months ended June 30, 2023 were higher than the U.S. statutory rate of 21.0% primarily due to state taxes, Internal Revenue Code Section 162(m) compensation limitations and foreign operations, partially offset by tax benefits for share based compensation deductions, research credits and acquisition adjustments.

14. Derivatives

In the normal course of business, the Company uses derivative financial instruments to manage foreign currency exchange rate risk. Currency exposure is monitored and managed by the Company as part of its risk management program which seeks to reduce the potentially adverse effects that market volatility could have on operating results. The Company’s derivative financial instruments consist of non-deliverable and deliverable foreign currency forward contracts. Derivative financial instruments are neither held nor issued by the Company for trading purposes.

Derivatives Not Designated as Hedging Instruments

Both the gain or loss on the derivatives not designated as hedging instruments and the offsetting loss or gain on the hedged item attributable to the hedged risk are recognized in current earnings. Realized gains or losses and changes in the estimated fair value of foreign currency forward contracts that have not been designated as hedges were a net loss of $1.0 million and net loss of $1.2 million during the three and six months ended June 30, 2024. Realized gains or losses and changes in the estimated fair value of foreign currency forward contracts that have not been designated as hedges were a net gain of $1.2 million and net gain of $1.6 million during the three and six months ended June 30, 2023. Gains and losses on these contracts are recorded in net other (income) expense and net interest (income) expense in the Unaudited Condensed Consolidated Statements of Operations and are offset by losses and gains on the related hedged items.

The notional amounts of the Company’s derivative instruments outstanding were as follows (in millions):


	June 30, 2024 (unaudited)		December 31, 2023
Derivatives not designated as hedges
Foreign exchange contracts	$	29.9	$	26.2
Total derivatives not designated as hedges	$	29.9	$	26.2

15. Fair Value Measurements

The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair value that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability

based on market data obtained from independent sources while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions.

The fair value hierarchy consists of the following three levels:

•Level 1 – Inputs are quoted prices in active markets for identical assets or liabilities.

•Level 2 – Inputs are quoted prices for similar assets or liabilities in an active market, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable and market-corroborated inputs which are derived principally from or corroborated by observable market data.

•Level 3 – Inputs are derived from valuation techniques in which one or more significant inputs or value drivers are unobservable.

The carrying value of cash, cash equivalents and restricted cash, accounts receivable, accounts payable, current liabilities and the revolving line of credit approximate fair value because of the short maturity of these instruments.

All highly liquid investments with maturities at date of purchase of three months or less are considered to be cash equivalents. Based on their short-term nature, the carrying value of cash equivalents approximate their fair value. As of June 30, 2024 and December 31, 2023, $55.2 million and $45.3 million, respectively of the Company’s cash, cash equivalents and restricted cash balance related to Level 1 investments.

The Company has a deferred compensation plan, which is funded through Company owned life insurance (“COLI”) policies. The COLI asset is carried at fair value derived from quoted market prices of investments within the COLI policies, which are considered Level 2 inputs. The fair value of the COLI asset was $14.3 million and $12.6 million as of June 30, 2024 and December 31, 2023, respectively.

The Company estimates the fair value of each foreign exchange forward contract by using the present value of expected cash flows. The estimate takes into account the difference between the current market forward price and contracted forward price for each foreign exchange contract and applies the difference in the rates to each outstanding contract. Valuations for all derivatives fall within Level 2 of the GAAP valuation hierarchy. The fair values of the Company’s derivative instruments outstanding as of June 30, 2024 and December 31, 2023 were immaterial.

The Company has contingent consideration liabilities related to acquisitions which are measured on a recurring basis and recorded at fair value, determined using the discounted cash flow method. The inputs used to calculate the fair value of the contingent consideration liabilities are considered to be Level 3 inputs due to the lack of relevant market activity and significant management judgment. An increase in future cash flows may result in a higher estimated fair value while a decrease in future cash flows may result in a lower estimated fair value of the contingent consideration liabilities. Remeasurements to fair value are recorded in adjustment to fair value of contingent consideration in the Unaudited Condensed Consolidated Statements of Operations. Refer to Note 8, Balance Sheet Components, for the estimated fair value of the contingent consideration liabilities as of June 30, 2024 and December 31, 2023.

The fair value of the Notes is measured using quoted price inputs. The Notes are not actively traded, and thus the price inputs represent a Level 2 measurement. As the quoted price inputs are highly variable from day to day, the fair value estimates could significantly increase or decrease.

The Notes are carried at their principal amount less unamortized issuance costs, and are not carried at fair value at each period end. The approximate fair value of the 2026 Notes as of June 30, 2024 and December 31, 2023 was $368.5 million and $316.1 million, respectively. The approximate fair value of the 2025 Notes as of June 30, 2024 and December 31, 2023 was $34.6 million and $32.4 million, respectively. The fair values were estimated on the basis of inputs that are observable in the market and are considered Level 2 fair value measurements.

16. Leases

The Company leases office space under various operating lease agreements, which have remaining lease terms of less than one year to seven years. Operating leases are included in operating lease right-of-use assets, other current liabilities, and operating lease liabilities on the consolidated balance sheet. Operating lease expense for the three and six months ended June 30, 2024 was $3.1 million and $6.1 million, respectively, and $3.2 million and $6.5 million for the three and six months ended June 30, 2023, respectively.

Supplemental balance sheet information related to leases was as follows (in millions):


	June 30, 2024 (unaudited)		December 31, 2023
Other current liabilities	$	6.6	$	7.0
Operating lease liabilities	17.4		16.4
Total	$	24.0	$	23.4

Future minimum lease payments as of June 30, 2024 were as follows (in millions):


	June 30, 2024 (unaudited)
2024 remaining	$	3.4
2025	7.4
2026	5.3
2027	4.7
2028	3.7
Thereafter	2.1
Total future lease payments	26.6
Less implied interest	(2.6)
Total	$	24.0

17. Commitments and Contingencies

From time to time the Company is involved in legal proceedings, claims and litigation related to employee claims, contractual disputes and taxes in the ordinary course of business. Although the Company cannot predict the outcome of such matters, currently the Company has no reason to believe the disposition of any current matter could reasonably be expected to have a material adverse impact on the Company’s financial position, results of operations or the ability to carry on any of its business activities.

Since the announcement of the Merger, complaints have been filed by purported stockholders of the Company in the United States District Court for the Southern District of New York (the “Federal Action”), the Circuit Court for St. Louis County in the State of Missouri (the “Missouri Action”), and the Supreme Court of the State of New York, County of New York (the “New York Actions”), in connection with the proposed Merger against us and the members of our Board of Directors and, in the Missouri Action, EQT Asia and certain of its affiliates party to the Merger Agreement in addition to us and the members of our Board of Directors. The Federal Action alleged that the Company and its Board of Directors violated Section 14(a) and Section 20(a) of the Securities Exchange Act of 1934, as amended, by materially omitting and/or misrepresenting certain material facts from the definitive proxy statement that relate to the transactions contemplated by the Merger Agreement. The Missouri Action alleged deficient disclosures and made other claims related to the definitive proxy statement under the state laws of Missouri. The Federal Action and the Missouri Action have been voluntarily dismissed. The New York Actions allege deficient disclosures and make other claims related to the definitive proxy statement under the state laws of New York. Among other remedies, the plaintiffs in each of the remaining complaints may seek to enjoin the consummation of the Merger. We have also received demand letters and draft complaints from purported stockholders of the Company regarding similar subject matter. The Company believes that the claims asserted in the filed complaints and the demand letters are without merit.

If the Merger Agreement is terminated under specific circumstances described in the Merger Agreement, we could be required to reimburse certain expenses of Parent or pay Parent a termination fee of $81.3 million.

See Note 2, Proposed Merger with Plano HoldCo Inc., an entity wholly-owned by funds affiliated with Baring Private Equity Asia, for further information regarding the Merger.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Statements made in this Form 10-Q, including without limitation this Management’s Discussion and Analysis of Financial Condition and Results of Operations, other than statements of historical information, are forward looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements may sometimes be identified by such words as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” or “continue” or the negative of those words and other comparable words. We believe that it is important to communicate our future expectations to investors. However, these forward-looking statements involve many risks and uncertainties. Our actual results could differ materially from those indicated in such forward-looking statements as a result of certain factors, including but not limited to, those set forth under “Risk Factors” in our Annual Report on Form 10-K previously filed with the SEC and elsewhere in this Form 10-Q. We are under no duty to update any of the forward-looking statements after the date of this Form 10-Q to conform these statements to actual results. For additional information, see the “Special Note Regarding Forward-Looking Statements” contained in this Form 10-Q.

Overview

Perficient is a global digital consultancy transforming how the world’s biggest brands connect with customers and grow their businesses. We help clients, primarily focused in North America, gain competitive advantage by using digital technology to: make their businesses more responsive to market opportunities; strengthen relationships with customers, suppliers, and partners; improve productivity; and reduce information technology costs. With unparalleled strategy, creative and technology capabilities, across industries, our end-to-end digital consulting services help our clients drive faster speed-to-market capabilities and stronger, more compelling experiences for consumers. We go to market with six primary service categories – strategy and transformation, data and intelligence, platforms and technology, customer experience and digital marketing, innovation and product development, and optimized global delivery. Within each service category, and collectively, we deliver a deep and broad portfolio of solutions that enable our clients to operate a real-time enterprise that dynamically adapts business processes and the systems that support them to meet the changing demands of a global and competitive marketplace.

Proposed Merger

The Company expects to incur significant costs, expenses and fees for professional services and other transaction costs in connection with the Merger Agreement. If the Merger Agreement is terminated under certain circumstances, the Company will be required to pay Parent a termination fee of $81.3 million, or Parent will be required to pay the Company a termination fee of $162.6 million as applicable. See Note 17, Commitments and Contingencies, of the notes to the accompanying interim unaudited condensed consolidated financial statements for information regarding litigation filed in respect of the Merger.

Services Revenues

Services revenues are derived from professional services that include developing, implementing, integrating, automating and extending business processes, technology infrastructure, and software applications. Professional services revenues are recognized over time as services are rendered. Most of our projects are performed on a time and materials basis, while a portion of our revenues is derived from projects performed on a fixed fee or fixed fee percent complete basis. For time and material projects, revenues are recognized and billed by multiplying the number of hours our professionals expend in the performance of the project by the hourly rates. For fixed fee contracts, revenues are recognized and billed by multiplying the established fixed rate per time period by the number of time periods elapsed. For fixed fee percent complete projects, revenues are generally recognized using an input method based on the ratio of hours expended to total estimated hours. Fixed fee percent complete engagements represented 6% and 7% of our services revenues for the three and six months ended June 30, 2024, and 7% for each of the three and six months ended June 30, 2023, respectively. On most projects, we are reimbursed for out-of-pocket expenses including travel and other project-related expenses. These reimbursements are included as a component of the transaction price of the respective professional services contract. The aggregate amount of reimbursed expenses will fluctuate depending on the location of our clients, the total number of our projects that require travel, and whether our arrangements with our clients provide for the reimbursement of such expenses. In conjunction with services provided, we occasionally receive referral fees under partner programs. These referral fees are recognized at a point in time when earned and recorded within services revenues.

Software and Hardware Revenues

Software and hardware revenues are derived from sales of third-party software and hardware resales, in which we are considered the agent, and sales of internally developed software, in which we are considered the principal. Revenues from sales of third-party software and hardware are recorded on a net basis, while revenues from internally developed software sales are recorded on a gross basis. Software and hardware revenues are expected to fluctuate depending on our clients’ demand for these products.

There are no significant cancellation or termination-type provisions for our software and hardware sales. Contracts for our professional services provide for a general right, to the client or us, to cancel or terminate the contract within a given period of time (generally 10 to 30 days’ notice is required). The client is responsible for any time and expenses incurred up to the date of cancellation or termination of the contract.

Cost of Revenues

Cost of revenues consists of cost of services, primarily related to cash and non-cash compensation and benefits (including bonuses and non-cash compensation related to equity awards), costs associated with subcontractors, reimbursable expenses and other project-related expenses. Cost of revenues does not include depreciation of assets used in the production of revenues which are primarily personal computers, servers, and other information technology related equipment. In accordance with Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers, sales of third-party software and hardware are presented on a net basis, and as such, third-party software and hardware costs are not presented within cost of revenues.

Our cost of services as a percentage of services revenues is affected by the utilization rates of our professionals (defined as the percentage of our professionals’ time billed to clients divided by the total available hours in the respective period), the salaries we pay our professionals, and the average billing rate we receive from our clients. If a project ends earlier than scheduled, we retain professionals in advance of receiving project assignments, or demand for our services declines, our utilization rate will decline and adversely affect our cost of services as a percentage of services revenues.

Selling, General, and Administrative Expenses

Selling, general and administrative (“SG&A”) expenses are primarily composed of sales-related costs, general and administrative salaries, stock compensation expense, office costs, recruiting expense, variable compensation costs, marketing costs and other miscellaneous expenses.

Results of Operations

Three months ended June 30, 2024 compared to three months ended June 30, 2023

Revenues. Total revenues decreased 3.6% to $222.8 million for the three months ended June 30, 2024 from $231.1 million for the three months ended June 30, 2023.


	Financial Results (in millions)						Explanation for Increases (Decreases) Over Prior Year Period (in millions)
	Three Months Ended June 30,				Total Decrease Over Prior Year Period		Increase Attributable to Revenue Delivered by Resources of Acquired Companies		Decrease Attributable to Revenue Delivered by Base Business Resources
	2024		2023
Services revenues	$	222.5	$	230.7	$	(8.2)	$	3.4	$	(11.6)
Software and hardware revenues	0.3		0.4		(0.1)		—		(0.1)
Total revenues	$	222.8	$	231.1	$	(8.3)	$	3.4	$	(11.7)

Services revenues decreased 3.6% to $222.5 million for the three months ended June 30, 2024 from $230.7 million for the three months ended June 30, 2023. The decrease in services revenues is primarily attributable to services revenues delivered by base business resources, which decreased $11.6 million, partially offset by an increase of $3.4 million in services revenues delivered by resources of acquired companies. Services revenues delivered by base business resources decreased primarily due to continued macroeconomic uncertainty and a slow down and delays in the initiation and ramp up of various projects. When analyzing revenue increases (decreases) by base business compared to acquired companies, revenue attributable to base business includes revenue from an acquired company that has been owned for a full four quarters after the date of acquisition.

Software and hardware revenues decreased to $0.3 million for the three months ended June 30, 2024 from $0.4 million for the three months ended June 30, 2023.

Cost of Revenues (exclusive of depreciation and amortization, discussed separately below). Cost of revenues decreased 2.8% to $142.1 million for the three months ended June 30, 2024 from $146.2 million for the three months ended June 30, 2023. Services costs as a percentage of services revenues increased to 63.9% for the three months ended June 30, 2024 from 63.4% for the three months ended June 30, 2023.

Selling, General and Administrative. SG&A expenses decreased to $43.8 million for the three months ended June 30, 2024 from $44.2 million for the three months ended June 30, 2023. SG&A expenses as a percentage of revenues were 19.6% and 19.1% for the three months ended June 30, 2024 and June 30, 2023, respectively.

Depreciation. Depreciation expense decreased to $1.8 million for the three months ended June 30, 2024 from $2.2 million for the three months ended June 30, 2023. Depreciation expense as a percentage of revenues was 0.8% and 1.0% for the three months ended June 30, 2024 and June 30, 2023, respectively.

Amortization. Amortization expense decreased to $4.9 million for the three months ended June 30, 2024 from $5.5 million for the three months ended June 30, 2023. Amortization expense as a percentage of revenues was 2.2% for the three months ended June 30, 2024 and 2.4% for the three months ended June 30, 2023. Amortization expense decreased primarily due to certain intangibles becoming fully amortized.

Acquisition Costs. Acquisition-related costs increased to $0.1 million for the three months ended June 30, 2024 from an immaterial amount for the three months ended June 30, 2023. Costs were incurred for legal, accounting, tax, investment bank and advisor fees, and valuation services performed by third parties in connection with acquisition-related activities.

Transaction Expenses. Transaction expenses increased to $6.7 million for the three months ended June 30, 2024 from zero for the three months ended June 30, 2023. Costs were incurred in connection with the transactions contemplated by the Merger Agreement.

Adjustment to Fair Value of Contingent Consideration. An adjustment of $2.7 million was recorded to decrease the liability during the three months ended June 30, 2023 which represents the net fair market value adjustment to Inflection Point

Systems, Inc. (“Inflection Point”) revenue and earnings-based contingent consideration liabilities, net of accretion for Inflection Point and Ameex Technologies Corporation (“Ameex”).

Net Interest (Income) Expense. Net interest income was $0.7 million for the three months ended June 30, 2024. Net interest expense was $0.3 million for the three months ended June 30, 2023. The change in net interest (income) expense was primarily due to a $1.0 million increase in interest income resulting from higher average cash balances and higher rates.

Provision for Income Taxes. We provide for federal, state and foreign income taxes at the applicable statutory rates adjusted for non-deductible expenses. Our effective tax rate increased to 27.8% for the three months ended June 30, 2024 from 24.9% for the three months ended June 30, 2023. The increase in effective tax rate was primarily due to a decrease in the tax benefits for acquisition adjustments compared to the prior year period.

Six months ended June 30, 2024 compared to six months ended June 30, 2023

Revenues. Total revenues decreased 5.3% to $438.1 million for the six months ended June 30, 2024 from $462.5 million for the six months ended June 30, 2023.


	Financial Results (in millions)						Explanation for Increases (Decreases) Over Prior Year Period (in millions)
	Six Months Ended June 30,				Total Decrease Over Prior Year Period		Increase Attributable to Revenue Delivered by Resources of Acquired Companies		Decrease Attributable to Revenue Delivered by Base Business Resources
	2024		2023
Services revenues	$	437.4	$	461.6	$	(24.2)	$	6.5	$	(30.7)
Software and hardware revenues	0.7		0.9		(0.2)		—		(0.2)
Total revenues	$	438.1	$	462.5	$	(24.4)	$	6.5	$	(30.9)

Services revenues decreased 5.2% to $437.4 million for the six months ended June 30, 2024 from $461.6 million for the six months ended June 30, 2023. The decrease in services revenues is primarily attributable to services revenues delivered by base business resources, which decreased $30.7 million, partially offset by an increase of $6.5 million in services revenues delivered by resources of acquired companies. Services revenues delivered by base business resources decreased primarily due to continued macroeconomic uncertainty and a slow down and delays in the initiation and ramp up of various projects. When analyzing revenue increases (decreases) by base business compared to acquired companies, revenue attributable to base business includes revenue from an acquired company that has been owned for a full four quarters after the date of acquisition.

Software and hardware revenues decreased to $0.7 million for the six months ended June 30, 2024 from $0.9 million for the six months ended June 30, 2023.

Cost of Revenues (exclusive of depreciation and amortization, discussed separately below). Cost of revenues decreased 2.1% to $284.2 million for the six months ended June 30, 2024 from $290.4 million for the six months ended June 30, 2023. Services costs as a percentage of services revenues increased to 65.0% for the six months ended June 30, 2024 from 62.9% for the six months ended June 30, 2023, primarily due to higher employee salaries as a percentage of services revenues.

Selling, General and Administrative. SG&A expenses increased to $92.9 million for the six months ended June 30, 2024 from $88.1 million for the six months ended June 30, 2023. SG&A expenses as a percentage of revenues were 21.2% and 19.0% for the six months ended June 30, 2024 and June 30, 2023, respectively. The increase in SG&A expenses was primarily due to a $5.6 million increase in stock compensation expense resulting from Jeffrey S. Davis’s resignation as Executive Chairman of the Company and certain amendments to his outstanding award agreements in connection with his resignation.

Depreciation. Depreciation expense decreased to $3.9 million for the six months ended June 30, 2024 from $4.5 million for the six months ended June 30, 2023. Depreciation expense as a percentage of revenues was 0.9% and 1.0% for the six months ended June 30, 2024 and June 30, 2023, respectively.

Amortization. Amortization expense decreased to $9.7 million for the six months ended June 30, 2024 from $11.3 million for the six months ended June 30, 2023. Amortization expense as a percentage of revenues was 2.2% for the six months ended June 30, 2024 and 2.5% for the six months ended June 30, 2023. Amortization expense decreased primarily due to certain intangibles becoming fully amortized.

Acquisition Costs. Acquisition-related costs increased to $1.1 million for the six months ended June 30, 2024 from an immaterial amount for the six months ended June 30, 2023. Costs were incurred for legal, accounting, tax, investment bank and advisor fees, and valuation services performed by third parties in connection with acquisition-related activities.

Transaction Expenses. Transaction-related expenses increased to $7.2 million for the six months ended June 30, 2024 from zero for the six months ended June 30, 2023. Costs were incurred in connection with the transactions contemplated by the Merger Agreement.

Adjustment to Fair Value of Contingent Consideration. An adjustment of $4.7 million was recorded to decrease the liability during the six months ended June 30, 2023 which represents the net fair market value adjustment to Inflection Point revenue and earnings-based contingent consideration liabilities, net of accretion for Inflection Point and Ameex.

Net Interest (Income) Expense. Net interest income was $1.5 million for the six months ended June 30, 2024. Net interest expense was $0.8 million for the six months ended June 30, 2023. The change in net interest (income) expense was primarily due to a $2.3 million increase in interest income resulting from higher average cash balances and higher rates.

Provision for Income Taxes. We provide for federal, state and foreign income taxes at the applicable statutory rates adjusted for non-deductible expenses. Our effective tax rate increased to 28.7% for the six months ended June 30, 2024 from 25.8% for the six months ended June 30, 2023. The increase in effective tax rate was primarily due to an increase in the effect of share-based compensation compared to the prior year period.

Liquidity and Capital Resources

Selected measures of liquidity and capital resources are as follows (in millions):


	June 30, 2024		December 31, 2023
Cash, cash equivalents and restricted cash (1)	$	112.9	$	128.9
Working capital (including cash, cash equivalents and restricted cash) (2)	$	257.0	$	247.5
Amounts available under credit facility	$	300.0	$	300.0

(1) The balance at June 30, 2024 includes $26.2 million held by certain foreign subsidiaries which is not available to fund domestic operations unless deemed repatriated. We currently do not plan or foresee a need to repatriate such funds. The balance also includes $2.4 million in cash held by certain other foreign subsidiaries which is available to fund domestic operations. The balance at December 31, 2023 includes $20.6 million held by certain foreign subsidiaries which is not available to fund domestic operations unless deemed repatriated and includes $1.8 million in cash held by certain other foreign subsidiaries which is available to fund domestic operations. The Company’s restricted cash balance was $0.2 million for June 30, 2024 and December 31, 2023.

(2) Working capital is total current assets less total current liabilities.

On May 5, 2024, we entered into the Merger Agreement, with Parent, and Merger Sub, with respect to the acquisition of the Company by Parent for $76.00 in cash for each share of Company common stock. We expect to incur significant costs, expenses and fees for professional services and other transaction costs in connection with the merger contemplated by the Merger Agreement. During the six months ended June 30, 2024, we incurred approximately $7.2 million as transaction costs in connection with the Merger. If the Merger Agreement is terminated under specified circumstances, we may be required to pay a termination fee of $81.3 million to Parent. For more information regarding the merger contemplated by the Merger Agreement and Merger Agreement, please see the definitive proxy statement filed with the SEC by the Company on June 26, 2024.

Net Cash Provided by Operating Activities

Net cash provided by operating activities for the six months ended June 30, 2024 was $29.3 million compared to net cash provided by operating activities of $65.1 million for the six months ended June 30, 2023. For the six months ended June 30, 2024, the primary components of operating cash flows were net income of $29.0 million, non-cash charges of $25.0 million and net operating asset investments of $24.7 million. For the six months ended June 30, 2023, the primary components of operating cash flows were net income of $53.2 million, non-cash charges of $18.6 million and net operating asset investments of $6.7 million. The increase in net operating asset investments is primarily related to accounts receivable, which increased

during the six months ended June 30, 2024 due to a delay in May invoicing resulting from our Enterprise Resource Planning (“ERP”) system implementation. However, we expect the changes in accounts receivable to normalize by the end of the third quarter.

Net Cash Used in Investing Activities

During the six months ended June 30, 2024, we used $3.2 million to purchase property and equipment and to develop software and $32.9 million for the acquisition of SMEDIX, Inc. During the six months ended June 30, 2023, we used $3.8 million to purchase property and equipment and to develop software and received proceeds of $0.3 million for a net working capital settlement related to an acquisition.

Net Cash Used in Financing Activities

During the six months ended June 30, 2024, we used $4.3 million to remit taxes withheld as part of a net share settlement of restricted stock vesting. We also used $4.5 million to settle contingent consideration for the purchase of Inflection Point and Ameex and received proceeds from sales of stock through the Employee Stock Purchase Plan of $0.5 million. During the six months ended June 30, 2023, we used $5.0 million to repurchase shares of our common stock through the stock repurchase program and $5.1 million to remit taxes withheld as part of a net share settlement of restricted stock vesting. We also used $0.8 million for credit facility financing fees, used $21.5 million to settle contingent consideration for the purchase of Talos LLC, Talos Digital LLC, Talos Digital SAS and TCOMM SAS (collectively, “Talos”) and Izmul S.A. (“Overactive”) and received proceeds from sales of stock through the Employee Stock Purchase Plan of $0.5 million.

Availability of Funds from Bank Line of Credit Facility

On March 29, 2023, the Company entered into the 2023 Credit Agreement with Wells Fargo Bank, National Association, as administrative agent and the other lenders parties thereto. The 2023 Credit Agreement provides for revolving credit borrowings up to a maximum principal amount of $300.0 million, subject to a commitment increase of $75.0 million. All outstanding amounts owed under the 2023 Credit Agreement become due and payable no later than the final maturity date of March 29, 2028. As of June 30, 2024, there was no outstanding balance under the 2023 Credit Agreement. The Company incurred $0.8 million of additional deferred financing fees during the six months ended June 30, 2023.

At June 30, 2024, the Company was in compliance with all covenants under the 2023 Credit Agreement.

Stock Repurchase Program

The Company’s Board of Directors authorized the repurchase of up to $375.0 million of Company common stock through a stock repurchase program expiring December 31, 2024. The program could be suspended or discontinued at any time based on market, economic, or business conditions. The timing and amount of repurchase transactions will be determined by management based on its evaluation of market conditions, share price, and other factors. Since the program’s inception on August 11, 2008, the Company has repurchased approximately $291.1 million (16.5 million shares) of outstanding common stock through June 30, 2024.

Cash Requirements from Contractual Obligations

For the six months ended June 30, 2024, there were no material changes outside the ordinary course of business in lease obligations or contractual obligations. See Note 16, Leases, in the Notes to Interim Condensed Consolidated Financial Statements for further description of our contractual obligations.

As of June 30, 2024 (unaudited) and December 31, 2023, there were no balances outstanding under the 2023 Credit Agreement. Any balances outstanding under the 2023 Credit Agreement would be classified as “Long-term debt” within the Condensed Consolidated Balance Sheet and become due and payable no later than the final maturity date of March 29, 2028. As of June 30, 2024, there were $398.0 million of outstanding 2026 Notes and 2025 Notes, net of unamortized issuance costs, compared to $396.9 million as of December 31, 2023. The amounts are classified as “Long-term debt” within the Condensed Consolidated Balance Sheets as of June 30, 2024 (unaudited) and December 31, 2023. The 2026 Notes will become due and payable no later than the final maturity date of November 15, 2026. The 2025 Notes will become due and payable no later than the final maturity date of August 1, 2025.

Conclusion

Of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheet as of June 30, 2024 (unaudited) of $112.9 million, $26.2 million was held by certain foreign subsidiaries and is considered to be indefinitely reinvested in those operations. The Company is able to fund its liquidity needs outside of these subsidiaries, primarily through cash flows generated by domestic operations and our credit facility. Therefore, the Company has no current plans to repatriate cash from these foreign subsidiaries in the foreseeable future. As of June 30, 2024, $2.4 million of the total cash, cash equivalents and restricted cash was held by certain other foreign subsidiaries, the earnings of which are not considered to be permanently reinvested and may be repatriated from time to time.

We believe that the currently available funds, access to capital from our credit facility, and cash flows generated from operations will be sufficient to meet our working capital requirements and other capital needs for the next 12 months.

Critical Accounting Policies

Our accounting policies are fully described in Note 2, Summary of Significant Accounting Policies, to our Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2023. We believe our most critical accounting policies include revenue recognition, purchase accounting and related fair value measurements, convertible debt, and income taxes.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We are exposed to market risks related to changes in foreign currency exchange rates and interest rates. We believe our exposure to market risks is immaterial.

Exchange Rate Sensitivity

We are exposed to market risks associated with changes in foreign currency exchange rates because we generate a portion of our revenues and incur a portion of our expenses in currencies other than the U.S. dollar. As of June 30, 2024, we were exposed to changes in exchange rates between the U.S. dollar and twelve other currencies. We hedge material foreign currency exchange rate exposures when feasible using forward contracts. These instruments are subject to fluctuations in foreign currency exchange rates and credit risk. Credit risk is managed through careful selection and ongoing evaluation of the financial institutions utilized as counterparties. Refer to Note 14, Derivatives, in the Notes to Interim Unaudited Condensed Consolidated Financial Statements for further discussion.

Interest Rate Sensitivity

As of June 30, 2024, there was no outstanding balance and $300.0 million of available borrowing capacity under our credit facility. To the extent we have outstanding borrowings under the credit facility, our interest expense will fluctuate as the interest rate for the line of credit floats based, at our option, on the prime rate plus a margin or the one-month SOFR rate plus a margin.

During the third quarter of 2020 and the fourth quarter of 2021, we issued the 2025 Notes and the 2026 Notes, respectively, which have a fixed interest rate of 1.250% and 0.125%, respectively. The fair value of the Notes may increase or decrease for various reasons, including fluctuations in the market price of our common stock, fluctuations in market interest rates and fluctuations in general economic conditions. Based upon the quoted market price as of June 30, 2024, the fair value of the 2025 Notes and 2026 Notes was approximately $34.6 million and $368.5 million, respectively.

We had unrestricted cash and cash equivalents totaling $112.7 million at June 30, 2024 (unaudited) and $128.7 million at December 31, 2023. The unrestricted cash and cash equivalents are primarily held for working capital purposes and acquisitions. We do not enter into investments for trading or speculative purposes.

Item 4. Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s reports under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the principal executive officer and principal financial officer of the Company, as appropriate, to allow timely decisions regarding required disclosure. The Company’s management, with the participation of the Company’s principal executive officer and principal financial officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this Form 10-Q. Based on that evaluation, the Company’s principal executive and principal financial officers have determined that the Company’s disclosure controls and procedures were effective.

Effective as of May 1, 2024, the Company implemented certain modules of an Enterprise Resource Planning (“ERP”) system to support the Company's future growth plan and to integrate significant processes. Implementing our ERP system resulted in significant changes in business processes and extensive organizational training. The Company believes it has taken and will continue to take the necessary steps to monitor and maintain appropriate internal controls during the transition period. These steps include deploying additional resources to mitigate internal control risks, and performing additional verifications and testing to ensure data integrity. The ERP system implementation resulted in a significant redesign of business processes, some of which relate to internal control over financial reporting and disclosure controls and procedures.

There were no other changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during three months ended June 30, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1A. Risk Factors

In evaluating all forward-looking statements, you should specifically consider various risk factors that may cause actual results to vary from those contained in the forward-looking statements. Our risk factors are described in our Annual Report on Form 10-K for the year ended December 31, 2023, as filed with the SEC on February 27, 2024 and available at www.sec.gov. There are no material changes to the Risk Factors described in our Annual Report on Form 10-K for the year ended December 31, 2023, other than as set forth below.

Risks Related to the Proposed Merger

We may not complete the proposed Merger within the time frame we anticipate or at all, which could have an adverse effect on our business, financial results and/or operations.

Completion of the Merger is subject to a number of closing conditions, including obtaining approval of our stockholders, which we received at a special meeting of our stockholders held on July 30, 2024, and receipt of required regulatory approvals or clearances. Each party’s obligation to consummate the Merger is also subject to the accuracy of the representations and warranties of the other party (subject to certain materiality qualifications) and the performance in all material respects of the other party’s covenants under the Merger Agreement, including, with respect to us, covenants regarding operation of our business prior to closing. In addition, the Merger Agreement may be terminated under certain specified circumstances. As a result, we cannot assure you that the Merger will be completed, or that, if completed, it will be exactly on the terms set forth in the Merger Agreement or within the expected time frame. See Note 2, Proposed Merger with Plano HoldCo Inc., an entity wholly-owned by funds affiliated with Baring Private Equity Asia, for further information regarding the Merger.

If the Merger is not completed within the expected time frame or at all, we may be subject to a number of material risks. The price of our common stock may decline to the extent that current market prices reflect a market assumption that the Merger will be completed. We could be required to reimburse certain expenses of Parent or pay Parent a termination fee if the Merger Agreement is terminated under specific circumstances described in the Merger Agreement. The failure to complete the Merger may result in negative publicity and negatively affect our relationship with our stockholders, employees and clients. We

may also be required to devote significant time and resources to litigation related to any failure to complete the Merger or related to any enforcement proceeding commenced against us to perform our obligations under the Merger Agreement.

The Merger Agreement provides us with limited remedies in the event of a breach by Parent that results in termination of the Merger Agreement, including the right to a reverse termination fee payable under certain specified circumstances, as described in the Merger Agreement. We cannot assure you that a remedy will be available to us in the event of such a breach or that the damages we incur in connection with such breach will not exceed the amount of the reverse termination fee.

The announcement and pendency of the Merger could adversely affect our business, financial results and/or operations.

Our efforts to complete the Merger could cause substantial disruptions in, and create uncertainty surrounding, our business, which may materially adversely affect our results of operation and our business. Uncertainty as to whether the Merger will be completed may affect our ability to recruit prospective employees or to retain and motivate existing employees. Employee retention may be particularly challenging while the Merger is pending because employees may experience uncertainty about their roles following the Merger. A substantial amount of our management’s and employees’ attention is being directed toward the completion of the Merger and thus is being diverted from our day-to-day operations. Uncertainty as to our future could adversely affect our business and our relationship with clients and potential clients. For example, clients and other counterparties may defer decisions concerning working with us, or seek to change existing business relationships with us. Changes to or termination of existing business relationships could adversely affect our revenue, earnings and financial condition, as well as the market price of our common stock. The adverse effects of the pendency of the Merger could be exacerbated by any delays in completion of the Merger or termination of the Merger Agreement.

While the Merger agreement is in effect, we are subject to restrictions on our business activities.

While the Merger Agreement is in effect, we are subject to restrictions on our business activities, including, among other things, restrictions on our ability to acquire other businesses and assets, dispose of our assets, make investments, enter into certain contracts, repurchase or issue securities, pay dividends, make capital expenditures, take certain actions relating to intellectual property, amend our organizational documents and incur indebtedness. These restrictions could prevent us from pursuing strategic business opportunities, taking actions with respect to our business that we may consider advantageous and responding effectively and/or timely to competitive pressures and industry developments, and may as a result materially adversely affect our business, results of operations and financial condition.

In certain instances, the Merger Agreement requires us to pay a termination fee to Parent, which could affect the decisions of a third party considering making an alternative acquisition proposal.

Under the terms of the Merger Agreement, we may be required to pay Parent a termination fee of up to $81.3 million under specified conditions. This payment could affect the structure, pricing and terms proposed by a third party seeking to acquire or merge with us and could discourage a third party from making a competing acquisition proposal, including a proposal that would be more favorable to our stockholders than the Merger.

We have incurred, and will continue to incur, direct and indirect costs as a result of the Merger.

We have incurred, and will continue to incur, significant costs and expenses, including fees for professional services and other transaction costs, in connection with the Merger. We must pay substantially all of these costs and expenses whether or not the Merger is completed. There are a number of factors beyond our control that could affect the total amount or the timing of these costs and expenses.

Legal proceedings in connection with the Merger, the outcomes of which are uncertain, could delay or prevent the completion of the Merger.

state laws of Missouri. The Federal Action and the Missouri Action have been voluntarily dismissed. The New York Actions allege deficient disclosures and make other claims related to the definitive proxy statement under the state laws of New York. Among other remedies, the plaintiffs in each of the remaining complaints may seek to enjoin the consummation of the Merger. We have also received demand letters and draft complaints from purported stockholders of the Company regarding similar subject matter. This and other potential legal proceedings could delay or prevent the Merger from becoming effective.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

The Company’s Board of Directors authorized the repurchase of up to $375.0 million of shares of Company common stock through a stock repurchase program expiring December 31, 2024. The Company originally announced the repurchase program on March 27, 2008 and announced its expansion to its current authorization on October 27, 2022. The program could be suspended or discontinued at any time based on market, economic, or business conditions. The Company has no other stock repurchase programs outstanding, nor did any stock repurchase programs expire during the three months ended June 30, 2024.

From the program’s inception on August 11, 2008 through June 30, 2024, we have repurchased approximately $291.1 million (16.5 million shares) of our outstanding common stock. The Company did not repurchase any shares through the stock repurchase program during the three months ended June 30, 2024.

The Company’s officers and directors are required to comply with the Company’s securities trading policy at all times, including during a repurchase program. The insider trading policy, among other things, prohibits trading in the Company’s securities when in possession of material non-public information and restricts the ability of directors and certain officers from transacting in the Company’s securities during specific blackout periods, subject to certain limited exceptions, including transactions pursuant to a Rule 10b5-1 trading arrangement that complies with the conditions of Exchange Act Rule 10b5-1.

Item 5. Other Information

Officer and Director Rule 10b5-1 Trading Arrangements

There were no Rule 10b5-1 trading arrangements adopted, materially modified, or terminated by our officers and directors during the second quarter of 2024.

Company Rule 10b5-1 Trading Arrangements

The Company did not adopt, materially modify, or terminate any Rule 10b5-1 trading arrangements during the second quarter of 2024.

Item 6. Exhibits

See Exhibits Index.

EXHIBITS INDEX


Exhibit Number			Description
2.1			A greement and Plan of Merger , b y and amo ng Plano HoldCo, Inc ., Plano BidCo, Inc. and Perfi cient, Inc., dated as of May 5, 2024, previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K filed May 6, 2024 and incorporated herein by reference
3.1			Amended and Restated Certificate of Incorporation of Perficient, Inc., previously filed with the Securities and Exchange Commission as an Exhibit to our Quarterly Report on Form 10-Q filed July 27, 2023 and incorporated herein by reference
3.2			Second Amended and Restated Bylaws of Perficient, Inc., previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K filed on July 27, 2023 (File No. 001-15169) and incorporated herein by reference
4.1			Specimen Certificate for shares of Perficient, Inc. common stock, previously filed with the Securities and Exchange Commission as an Exhibit to our Quarterly Report on Form 10-Q (File No. 001-15169) filed May 7, 2009 and incorporated herein by reference
4.2			Indenture, dated August 14, 2020, between Perficient, Inc. and U.S. Bank National Association, as trustee, relating to the Company’s 1.250% Convertible Senior Notes due 2025, previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K (File No. 001-15169) filed August 18, 2020 and incorporated herein by reference
4.3			Form of 1.250% Convertible Senior Notes due 2025, previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K filed August 18, 2020 and incorporated herein by reference
4.4			Indenture, dated November 9, 2021, between Perficient, Inc. and U.S. Bank National Associate, as trustee, relating to the Company's 0.125% Convertible Senior Notes due 2026, previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K filed November 9, 2021 and incorporated herein by reference
4.5			Form of 0.125% Convertible Senior Notes due 2026, previously filed with the Securities and Exchange Commission as an Exhibit to our Current Report on Form 8-K filed November 9, 2021 and incorporated herein by reference
31.1*			Certification by the Chief Executive Officer of Perficient, Inc. as required by Section 302 of the Sarbanes-Oxley Act of 2002
31.2*			Certification by the Chief Financial Officer of Perficient, Inc. as required by Section 302 of the Sarbanes-Oxley Act of 2002
32.1**			Certification by the Chief Executive Officer and Chief Financial Officer of Perficient, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101*			The following financial information from Perficient, Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2024 formatted in iXBRL (inline eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of June 30, 2024 (Unaudited) and December 31, 2023, (ii) Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2024 and 2023, (iii) Unaudited Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2024 and 2023, (iv) Unaudited Condensed Consolidated Statements of Shareholders’ Equity for the three and six months ended June 30, 2024 and 2023, (v) Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2024 and 2023, and (vi) the Notes to Interim Unaudited Condensed Consolidated Financial Statements
104			Cover Page Interactive Data File (formatted as iXBRL and contained in Exhibit 101)

†			Identifies an Exhibit that consists of or includes a management contract or compensatory plan or arrangement.
*			Filed herewith.
**			Included but not to be considered “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.
***			All schedules to the Merger Agreement have been omitted pursuant to Item 601(b) (2) of Regulation S-K. The Company hereby agrees to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


		PERFICIENT, INC.

Date:	August 8, 2024	By:	/s/ Thomas J. Hogan
			Thomas J. Hogan
			Chief Executive Officer (Principal Executive Officer)


Date:	August 8, 2024	By:	/s/ Paul E. Martin
			Paul E. Martin
			Chief Financial Officer (Principal Financial Officer)

EXHIBIT 31.1

CERTIFICATIONS

I, Thomas J. Hogan, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Perficient, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date:	August 8, 2024	By:	/s/ Thomas J. Hogan
			Thomas J. Hogan
			Chief Executive Officer

EXHIBIT 31.2

CERTIFICATIONS

I, Paul E. Martin, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Perficient, Inc.;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



Date:	August 8, 2024	By:	/s/ Paul E. Martin
			Paul E. Martin
			Chief Financial Officer

EXHIBIT 32.1

CERTIFICATION OF

CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

Pursuant to 18 U.S.C. Sec. 1350 and in connection with the accompanying report on Form 10-Q for the quarterly period ended June 30, 2024, that contains financial statements of Perficient, Inc. (the “Company”) filed for such period and that is being filed concurrently with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers of the Company hereby certify that:


1.			The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2.			The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date:	August 8, 2024	By:	/s/ Thomas J. Hogan
			Thomas J. Hogan
			Chief Executive Officer (Principal Executive Officer)


Date:	August 8, 2024	By:	/s/ Paul E. Martin
			Paul E. Martin
			Chief Financial Officer (Principal Financial Officer)

Cover Page - shares	6 Months Ended
Cover Page - shares	Jun. 30, 2024	Jul. 25, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2024
Document Transition Report	false
Entity File Number	001-15169
Entity Registrant Name	PERFICIENT, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	74-2853258
Entity Address, Address Line One	555 Maryville University Drive
Entity Address, Address Line Two	Suite 600
Entity Address, City or Town	Saint Louis
Entity Address, State or Province	MO
Entity Address, Postal Zip Code	63141
City Area Code	314
Local Phone Number	529-3600
Title of 12(b) Security	Common Stock, $0.001 par value
Trading Symbol	PRFT
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		35,156,654
Entity Central Index Key	0001085869
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash, cash equivalents and restricted cash	$ 112,937	$ 128,886
Accounts receivable, net	195,954	178,998
Prepaid expenses	6,219	5,638
Other current assets	23,298	12,431
Total current assets	338,408	325,953
Property and equipment, net	8,504	11,996
Operating lease right-of-use assets	22,521	21,786
Goodwill	608,774	581,387
Intangible assets, net	70,529	71,118
Other non-current assets	64,542	52,364
Total assets	1,113,278	1,064,604
Current liabilities:
Accounts payable	15,083	18,688
Other current liabilities	66,355	59,784
Total current liabilities	81,438	78,472
Long-term debt, net	398,018	396,874
Operating lease liabilities	17,420	16,446
Other non-current liabilities	45,600	42,189
Total liabilities	542,476	533,981
Stockholders’ equity:
Preferred stock (par value $0.001 per share; 8,000,000 authorized; no shares issued or outstanding as of June 30, 2024 and December 31, 2023)	0	0
Common stock (par value $0.001 per share; 100,000,000 authorized; 53,857,809 shares issued and 34,477,233 shares outstanding as of June 30, 2024; 53,465,127 shares issued and 34,174,200 shares outstanding as of December 31, 2023)	54	53
Additional paid-in capital	454,853	432,160
Accumulated other comprehensive loss	(12,504)	(5,461)
Treasury stock, at cost (19,380,576 shares as of June 30, 2024; 19,290,927 shares as of December 31, 2023)	(377,790)	(373,325)
Retained earnings	506,189	477,196
Total stockholders’ equity	570,802	530,623
Total liabilities and stockholders’ equity	$ 1,113,278	$ 1,064,604

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	8,000,000	8,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	53,857,809	53,465,127
Common stock, shares outstanding	34,477,233	34,174,200
Treasury stock, shares	19,380,576	19,290,927

Unaudited Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues
Revenues	$ 222,817	$ 231,105	$ 438,121	$ 462,513
Cost of revenues (cost of services, exclusive of depreciation and amortization, shown separately below)
Cost of services	139,535	143,560	279,134	285,248
Stock compensation	2,535	2,608	5,042	5,132
Total cost of revenues	142,070	146,168	284,176	290,380
Selling, General and Administrative Expense [Abstract]
Selling, general and administrative	40,027	39,390	79,270	78,994
Stock compensation	3,731	4,787	13,654	9,103
Total selling, general and administrative	43,758	44,177	92,924	88,097
Depreciation	1,840	2,224	3,851	4,529
Amortization	4,862	5,523	9,748	11,340
Acquisition costs	132	(71)	1,050	8
Transaction expenses	6,688	0	7,163	0
Adjustment to fair value of contingent consideration	67	(2,701)	108	(4,727)
Income from operations	23,400	35,785	39,101	72,886
Net interest (income) expense	(729)	296	(1,496)	801
Net other (income) expense	(15)	387	(60)	462
Income before income taxes	24,144	35,102	40,657	71,623
Provision for income taxes	6,706	8,740	11,664	18,461
Net income	$ 17,438	$ 26,362	$ 28,993	$ 53,162
Basic net income per share (in dollars per share)	$ 0.51	$ 0.78	$ 0.85	$ 1.57
Diluted net income per share (in dollars per share)	$ 0.49	$ 0.73	$ 0.81	$ 1.48
Shares used in computing basic net income per share (in shares)	34,353	33,988	34,251	33,951
Shares used in computing diluted net income per share (in shares)	37,072	36,717	36,988	36,707

Unaudited Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 17,438	$ 26,362	$ 28,993	$ 53,162
Other comprehensive (loss) income:
Foreign currency translation adjustment, net of tax	(6,168)	5,605	(7,043)	7,377
Comprehensive income	$ 11,270	$ 31,967	$ 21,950	$ 60,539

Unaudited Condensed Consolidated Statement of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Treasury Stock, Common	Accumulated Other Comprehensive Loss	Retained Earnings
Balance at Dec. 31, 2022		$ 53	$ 403,866	$ (354,536)	$ (17,519)	$ 378,263
Balance (in shares) at Dec. 31, 2022	34,072,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation related to restricted stock vesting and retirement savings plan contributions		0	13,739
Issuance of stock in conjunction with acquisition including stock attributed to future compensation			0
Proceeds from the sales of stock through the Employee Stock Purchase Plan (in shares)	8,000
Proceeds from the sales of stock through the Employee Stock Purchase Plan			518
Stock compensation related to restricted stock vesting and retirement savings plan contributions (in shares)	208,000
Purchases of treasury stock and buyback of shares for taxes (in shares)	(141,000)
Foreign currency translation adjustment	$ 7,377				7,377
Purchases of treasury stock and buyback of shares for taxes				(10,068)
Escrow Shares Reqcquired				(164)
Net income	53,162					53,162
Balance at Jun. 30, 2023	$ 474,691	53	418,123	(364,768)	(10,142)	431,425
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock in conjunction with acquisition (in shares)	0
Stock reacquired for escrow claim (in shares)	(2,000)
Balance (in shares) at Jun. 30, 2023	34,145,000
Balance at Mar. 31, 2023		53	410,959	(362,149)	(15,747)	405,063
Balance (in shares) at Mar. 31, 2023	34,159,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation related to restricted stock vesting and retirement savings plan contributions		0	6,886
Issuance of stock in conjunction with acquisition including stock attributed to future compensation			0
Proceeds from the sales of stock through the Employee Stock Purchase Plan (in shares)	4,000
Proceeds from the sales of stock through the Employee Stock Purchase Plan			278
Stock compensation related to restricted stock vesting and retirement savings plan contributions (in shares)	17,000
Purchases of treasury stock and buyback of shares for taxes (in shares)	(35,000)
Foreign currency translation adjustment	$ 5,605				5,605
Purchases of treasury stock and buyback of shares for taxes				(2,619)
Escrow Shares Reqcquired				0
Net income	26,362					26,362
Balance at Jun. 30, 2023	$ 474,691	53	418,123	(364,768)	(10,142)	431,425
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock in conjunction with acquisition (in shares)	0
Stock reacquired for escrow claim (in shares)	0
Balance (in shares) at Jun. 30, 2023	34,145,000
Balance at Dec. 31, 2023	$ 530,623	53	432,160	(373,325)	(5,461)	477,196
Balance (in shares) at Dec. 31, 2023	34,174,200
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation related to restricted stock vesting and retirement savings plan contributions		1	18,217
Issuance of stock in conjunction with acquisition including stock attributed to future compensation			3,992
Proceeds from the sales of stock through the Employee Stock Purchase Plan (in shares)	9,000
Proceeds from the sales of stock through the Employee Stock Purchase Plan			484
Stock compensation related to restricted stock vesting and retirement savings plan contributions (in shares)	316,000
Purchases of treasury stock and buyback of shares for taxes (in shares)	(87,000)
Foreign currency translation adjustment	$ (7,043)				(7,043)
Purchases of treasury stock and buyback of shares for taxes				(4,273)
Escrow Shares Reqcquired				(192)
Net income	28,993					28,993
Balance at Jun. 30, 2024	$ 570,802	54	454,853	(377,790)	(12,504)	506,189
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock in conjunction with acquisition (in shares)	68,000
Stock reacquired for escrow claim (in shares)	(3,000)
Balance (in shares) at Jun. 30, 2024	34,477,233
Balance at Mar. 31, 2024		54	448,855	(377,594)	(6,336)	488,751
Balance (in shares) at Mar. 31, 2024	34,456,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock compensation related to restricted stock vesting and retirement savings plan contributions		0	5,711
Issuance of stock in conjunction with acquisition including stock attributed to future compensation			0
Proceeds from the sales of stock through the Employee Stock Purchase Plan (in shares)	6,000
Proceeds from the sales of stock through the Employee Stock Purchase Plan			287
Stock compensation related to restricted stock vesting and retirement savings plan contributions (in shares)	18,000
Purchases of treasury stock and buyback of shares for taxes (in shares)	0
Foreign currency translation adjustment	$ (6,168)				(6,168)
Purchases of treasury stock and buyback of shares for taxes				(4)
Escrow Shares Reqcquired				(192)
Net income	17,438					17,438
Balance at Jun. 30, 2024	$ 570,802	$ 54	$ 454,853	$ (377,790)	$ (12,504)	$ 506,189
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of stock in conjunction with acquisition (in shares)	0
Stock reacquired for escrow claim (in shares)	(3,000)
Balance (in shares) at Jun. 30, 2024	34,477,233

Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Operating Activities
Net income	$ 28,993	$ 53,162
Adjustments to reconcile net income to net cash provided by operations:
Depreciation	3,851	4,529
Amortization	9,748	11,340
Deferred income taxes	(8,151)	(7,548)
Non-cash stock compensation and retirement savings plan contributions	18,129	13,829
Amortization of debt issuance costs	1,263	1,239
Adjustment to fair value of contingent consideration for purchase of businesses	108	(4,727)
Changes in operating assets and liabilities, net of business acquisitions:
Accounts receivable	(13,665)	16,168
Other assets	(14,741)	(1,061)
Accounts payable	(3,662)	(8,224)
Other liabilities	7,379	(13,596)
Net cash provided by operating activities	29,252	65,111
Investing Activities
Purchase of property and equipment	(2,568)	(3,200)
Capitalization of internally developed software costs	(672)	(607)
Purchase of businesses, net of cash acquired	(32,940)	254
Net cash used in investing activities	(36,180)	(3,553)
Financing Activities
Payment for credit facility financing fees	0	(750)
Payment of contingent consideration for purchase of business	(4,516)	(21,530)
Proceeds from the sale of stock through the Employee Stock Purchase Plan	484	518
Purchases of treasury stock	0	(4,991)
Remittance of taxes withheld as part of a net share settlement of restricted stock vesting	(4,273)	(5,077)
Net cash used in financing activities	(8,305)	(31,830)
Effect of exchange rate on cash, cash equivalents and restricted cash	(716)	613
Change in cash, cash equivalents and restricted cash	(15,949)	30,341
Cash, cash equivalents and restricted cash at beginning of period	128,886	30,130
Cash, cash equivalents and restricted cash at end of period	112,937	60,471
Supplemental Disclosures:
Cash paid for income taxes	26,549	25,764
Cash paid for interest	650	416
Stock issued for purchase of businesses, net of stock reacquired for escrow claim	3,617	(164)
Liability incurred for purchase of property and equipment	$ 0	$ 190

Basis of Presentation	6 Months Ended
Basis of Presentation	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation The accompanying interim unaudited condensed consolidated financial statements of Perficient, Inc. and its subsidiaries (collectively, the “Company”) have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and are presented in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) applicable to interim financial information. Accordingly, certain note disclosures have been condensed or omitted. In the opinion of management, the interim unaudited condensed consolidated financial statements reflect all adjustments (consisting of only normal recurring adjustments) necessary for a fair presentation of the Company’s financial position, results of operations and cash flows for the periods presented. These financial statements should be read in conjunction with the Company’s consolidated financial statements and notes thereto filed with the SEC in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023. Certain reclassifications were made to prior year amounts to conform to the 2024 presentation.

Proposed Merger with Plano HoldCo Inc., an entity wholly-owned by funds affiliated with Baring Private Equity Asia	6 Months Ended
	Jun. 30, 2024
Business Combination and Asset Acquisition [Abstract]
Proposed Merger with Plano HoldCo Inc., an entity wholly-owned by funds affiliated with Baring Private Equity Asia	Proposed Merger with Plano HoldCo Inc., an entity wholly-owned by funds affiliated with Baring Private Equity Asia On May 5, 2024, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Plano HoldCo, Inc., a Delaware corporation (“Parent”), and Plano BidCo, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”). Parent and Merger Sub are affiliates of BPEA Private Equity Fund VIII (“EQT Asia”). Pursuant to the Merger Agreement, Merger Sub will be merged with and into the Company, with the Company surviving as a wholly owned subsidiary of Parent (the “Merger” and, collectively with the other transactions contemplated by the Merger Agreement, the “Transactions”). Under the terms of the Merger Agreement, the Company’s stockholders will receive $76.00 in cash per share of Company common stock outstanding as of the closing of the Merger. Consummation of the Merger is subject to various conditions, including, among others, customary conditions relating to the adoption of the Merger Agreement by the holders of a majority of the Company’s outstanding common stock, the expiration or termination of any applicable waiting periods under the Hart-Scott-Rodino Act (the “HSR Act”), conclusion of any review or investigation of the Transactions by the Committee on Foreign Investment in the United States, the receipt of certain foreign regulatory approvals and other customary conditions for a transaction of this type, such as the absence of any legal restraint prohibiting the consummation of the Transactions and the absence of any Company Material Adverse Effect (as defined in the Merger Agreement). Consummation of the Merger is not subject to any financing condition, and is expected to occur by the end of 2024. The HSR Act waiting period expired on July 1, 2024. On July 30, 2024, at a special meeting of stockholders, the stockholders of the Company approved and adopted the Merger Agreement. The closing of the Merger remains subject to the satisfaction or waiver of the remaining conditions to the Merger set forth in the Merger Agreement, including, among other things, the receipt of approvals required by relevant governmental authorities under foreign investment laws in Romania, and the receipt of the CFIUS Approval without the imposition of a Burdensome Condition (as defined in the Merger Agreement). The Company expects to incur significant costs, expenses and fees for professional services and other transaction costs in connection with the Merger Agreement. If the Merger Agreement is terminated under certain circumstances, the Company will be required to pay Parent a termination fee of $81.3 million, or Parent will be required to pay the Company a termination fee of $162.6 million as applicable. See Note 17, Commitments and Contingencies, for information regarding litigation filed in respect of the Merger.

Summary of Significant Accounting Policies	6 Months Ended
Summary of Significant Accounting Policies	Jun. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates, and such differences could be material to the financial statements. There have been no changes to significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, 2023 that have had a material impact on the Company’s condensed consolidated financial statements and related notes.

Recent Accounting Pronouncements	6 Months Ended
Recent Accounting Pronouncements	Jun. 30, 2024
Accounting Standards Update and Change in Accounting Principle [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements In November 2023, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2023-07, Segment Reporting (Topic 280) Improvements To Reportable Segment Disclosures, which requires additional disclosures about a public entity’s reportable segments and addresses requests from investors and other allocators of capital for additional, more detailed information about a reportable segment’s expenses. The Company will adopt this ASU retrospectively for the annual period beginning on January 1, 2024 and for interim periods beginning on January 1, 2025. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740) Improvements To Income Tax Disclosures, which requires additional disclosures of income tax components that affect the rate reconciliation and income taxes paid, broken out by the applicable taxing jurisdictions. The Company expects to adopt this ASU prospectively for the annual period beginning on January 1, 2025.

Revenue

6 Months Ended

Jun. 30, 2024

Revenue from Contract with Customer [Abstract]

Revenue

Services Revenues

Software and Hardware Revenues

Arrangements with Multiple Performance Obligations

Contract Costs

Deferred Revenue

Transaction Price Allocated to Remaining Performance Obligations

Disaggregation of Revenue

The following tables present revenue disaggregated by revenue source and pattern of revenue recognition (in millions):


	Three Months Ended June 30,
	2024						2023
	Over Time		Point In Time		Total Revenues		Over Time		Point In Time		Total Revenues
Time and materials contracts	$	160.1	$	—	$	160.1	$	170.6	$	—	$	170.6
Fixed fee percent complete contracts	13.9		—		13.9		16.2		—		16.2
Fixed fee contracts	45.5		—		45.5		41.2		—		41.2
Reimbursable expenses	2.9		—		2.9		2.1		—		2.1
Total professional services fees	222.4		—		222.4		230.1		—		230.1
Other services revenue*	—		0.1		0.1		—		0.6		0.6
Total services	222.4		0.1		222.5		230.1		0.6		230.7
Software and hardware	—		0.3		0.3		—		0.4		0.4
Total revenues	$	222.4	$	0.4	$	222.8	$	230.1	$	1.0	$	231.1

*Other services revenue primarily consists of partner referral fees. These referral fees are recognized at a point in time when earned and recorded within services revenues.


	Six Months Ended June 30,
	2024						2023
	Over Time		Point In Time		Total Revenues		Over Time		Point In Time		Total Revenues
Time and materials contracts	$	314.3	$	—	$	314.3	$	346.1	$	—	$	346.1
Fixed fee percent complete contracts	28.7		—		28.7		31.0		—		31.0
Fixed fee contracts	87.5		—		87.5		78.9		—		78.9
Reimbursable expenses	6.5		—		6.5		4.6		—		4.6
Total professional services fees	437.0		—		437.0		460.6		—		460.6
Other services revenue*	—		0.4		0.4		—		1.0		1.0
Total services	437.0		0.4		437.4		460.6		1.0		461.6
Software and hardware	—		0.7		0.7		—		0.9		0.9
Total revenues	$	437.0	$	1.1	$	438.1	$	460.6	$	1.9	$	462.5

*Other services revenue primarily consists of partner referral fees. These referral fees are recognized at a point in time when earned and recorded within services revenues.

The following table presents revenue disaggregated by geographic area, as determined by the billing address of customers (in millions):


	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
United States	$	211.1	$	223.0	$	416.7	$	446.5
Other countries	11.7		8.1		21.4		16.0
Total revenues	$	222.8	$	231.1	$	438.1	$	462.5

Stock-Based Compensation

6 Months Ended

Jun. 30, 2024

Share-Based Payment Arrangement [Abstract]

Stock-Based Compensation

Restricted Stock Awards (“RSAs”)

Restricted stock activity for the six months ended June 30, 2024 was as follows (shares in thousands):


	RSAs (Shares)	Weighted-Average Grant Date Fair Value
Restricted stock awards outstanding at December 31, 2023	714	$	70.80
Awards granted	195	69.00
Awards vested	(197)	73.73
Awards forfeited	(36)	66.25
Restricted stock awards outstanding at June 30, 2024	676	$	69.68

As of June 30, 2024, there was $31.2 million of total unrecognized compensation cost related to non-vested RSAs with a weighted-average remaining life of two years.

Performance Stock Awards (“PSAs”)

Net Income per Share

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

Net Income per Share

The following table presents the calculation of basic and diluted net income per share (in thousands, except per share information):


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Net income, basic	$	17,438	$	26,362	$	28,993	$	53,162
Add back interest expense on convertible notes, net of tax	551		573		1,088		1,133
Net income, diluted	$	17,989	$	26,935	$	30,081	$	54,295

Basic:
Weighted-average shares of common stock outstanding	34,353		33,988		34,251		33,951
Shares used in computing basic net income per share	34,353		33,988		34,251		33,951
Effect of dilutive securities:
Restricted stock and performance stock awards subject to vesting	173		133		175		144
Shares issuable for acquisition consideration (1)	116		166		132		182
Shares issuable for conversion of convertible senior notes	2,430		2,430		2,430		2,430

Shares used in computing diluted net income per share	37,072		36,717		36,988		36,707

Basic net income per share	$	0.51	$	0.78	$	0.85	$	1.57
Diluted net income per share	$	0.49	$	0.73	$	0.81	$	1.48

The number of anti-dilutive securities not included in the calculation of diluted net income per share were as follows (in thousands):


	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2024	2023	2024	2023
Restricted stock and performance stock awards subject to vesting	121	144	115	210

Warrants related to the issuance of convertible senior notes	2,431	2,431	2,431	2,431
Total anti-dilutive securities	2,552	2,575	2,546	2,641

See Note 12, Long-term Debt for further information on the convertible senior notes and warrants related to the issuance of convertible notes.

Balance Sheet Components

6 Months Ended

Jun. 30, 2024

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Components


	June 30, 2024 (unaudited)		December 31, 2023
Accounts receivable:	(in millions)
Billed accounts receivable, net	$	96.1	$	119.9
Unbilled revenues, net	99.9		59.1
Total	$	196.0	$	179.0


Other current assets:
Miscellaneous receivables	$	3.6	$	3.1
Contractual commitment asset	5.1		3.0
Income tax receivable	10.5		2.7
Other current assets	4.1		3.6
Total	$	23.3	$	12.4


Property and equipment:
Computer hardware (useful life of 3 years)	$	25.1	$	26.7
Software (useful life of 1 to 7 years)	8.7		9.2
Furniture and fixtures (useful life of 5 years)	4.3		4.5
Leasehold improvements (useful life of 5 years)	7.6		7.8
Less: Accumulated depreciation	(37.2)		(36.2)
Total	$	8.5	$	12.0



Other non-current assets:
Non-current unbilled revenue	$	1.4	$	2.2
Company owned life insurance asset	14.3		12.6
Long term deposits	1.9		1.8
Credit facility deferred financing fees, net	0.9		1.0
Other non-current assets	17.1		13.2
Deferred income taxes	28.9		21.6
Total	$	64.5	$	52.4



Other current liabilities:
Estimated fair value of contingent consideration liability (Note 10)	$	6.5	$	4.5
Accrued variable compensation	22.1		15.9
Current operating lease liabilities	6.6		7.0
Payroll related costs	12.1		11.1
Deferred revenues	1.6		5.5
Income tax payable	1.3		1.5
Other current liabilities	7.1		4.8
Accrued medical claims expense	2.3		3.2
Professional fees	3.3		1.3
Accrued IT expenses	3.5		5.0
Total	$	66.4	$	59.8


	June 30, 2024 (unaudited)		December 31, 2023
Other non-current liabilities:	(in millions)
Deferred income taxes	$	4.8	$	5.9
Reserve for uncertain tax positions	19.0		17.7
Deferred compensation liability	12.5		11.0
Other non-current liabilities	7.6		5.0
Non-current software accrual	1.7		2.6
Total	$	45.6	$	42.2

Allowance for Credit Losses

6 Months Ended

Jun. 30, 2024

Credit Loss [Abstract]

Allowance for Credit Losses

Activity in the allowance for credit losses is summarized as follows (in millions):


	Six Months Ended June 30,
	2024		2023


Opening balance at January 1	$	2.5	$	5.8
Charges to expense, net of recoveries	0.2		(0.3)
Other (1)	(0.2)		(2.0)
Balance at June 30	$	2.5	$	3.5

(1) Other is primarily related to uncollected balances written off and currency translation adjustments.

Business Combinations

6 Months Ended

Jun. 30, 2024

Business Combinations [Abstract]

Business Combinations

2024 Acquisition

The acquisition date fair value of the consideration transferred for SMEDIX consisted of the following (in millions):


	SMEDIX
Cash, net of cash acquired	$	32.9
Company common stock issued at closing	3.8
Contingent consideration (1)	6.4		(2)
Net working capital adjustment due to the seller(s)	0.2
Total allocable purchase price consideration	$	43.3

(2)The maximum cash payout that may be realized by the sellers in the SMEDIX acquisition is $14.4 million. As of June 30, 2024, the fair value of the contingent consideration was $6.5 million.


	SMEDIX
Acquired tangible assets	$	5.1
Identified intangible assets	8.9
Liabilities assumed	(3.2)
Goodwill	32.5
Total allocable purchase price consideration	$	43.3

The following table presents details of the intangible assets acquired during the three months ended June 30, 2024.

Weighted Average Useful Life

Estimated Useful Life

SMEDIX

Customer relationships

6 years

7.0

Customer backlog

1 year

1.7

Non-compete agreements

5 years

0.1

Trade name

1 year

0.1

Total acquired intangible assets

8.9

Pro-forma Results of Operations

Pro-forma results of operations have not been presented for SMEDIX because the effect of the acquisition on the Company's condensed consolidated financial statements was not material.

Goodwill and Intangible Assets

6 Months Ended

Jun. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

Goodwill

The changes in the carrying amount of goodwill for the six months ended June 30, 2024 are as follows (in millions):


Balance at December 31, 2023	$	581.4
Purchase price allocation for SMEDIX	32.5
Effect of foreign currency translation adjustments	(5.1)
Balance at June 30, 2024	$	608.8

Intangible Assets with Definite Lives

The following table presents a summary of the Company’s intangible assets that are subject to amortization (in millions):


	June 30, 2024 (unaudited)						December 31, 2023
	Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts		Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts
Customer relationships	$	114.2	$	(46.7)	$	67.5	$	116.1	$	(47.3)	$	68.8
Non-compete agreements	1.2		(0.7)		0.5		1.1		(0.6)		0.5
Customer backlog	1.7		(0.8)		0.9		—		—		—
Trade name	0.9		(0.8)		0.1		0.8		(0.8)		—
Developed software	9.1		(7.6)		1.5		8.5		(6.7)		1.8
Total	$	127.1	$	(56.6)	$	70.5	$	126.5	$	(55.4)	$	71.1

The estimated useful lives of identifiable intangible assets are as follows:


Customer relationships			5 - 10 years
Non-compete agreements			4 - 5 years
Customer backlog			1 year
Trade name			1 year
Developed software			1 - 7 years

Estimated annual amortization expense for the next five years ended December 31 and thereafter is as follows (in millions):


2024 remaining	$	9.0
2025	$	13.4
2026	$	10.9
2027	$	8.5
2028	$	7.4
Thereafter	$	21.3

Long-term Debt

6 Months Ended

Jun. 30, 2024

Debt Disclosure [Abstract]

Long-term Debt

Revolving Credit Facility

The Company is required to comply with various financial covenants under the 2023 Credit Agreement. At June 30, 2024, the Company was in compliance with all covenants under the 2023 Credit Agreement.

Convertible Senior Notes due 2026

Convertible Senior Notes due 2025

Other Terms of the Notes

•upon the occurrence of certain corporate events or distributions on the Company’s common stock described in the 2025 Indenture and 2026 Indenture; and

The 2025 Notes and 2026 Notes consisted of the following (in millions):


	June 30, 2024 (unaudited)
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3
Less: Unamortized debt issuance costs	(5.1)		(0.2)
Net carrying amount	$	374.9	$	23.1


	December 31, 2023
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3

Less: Unamortized debt issuance costs	(6.1)		(0.3)
Net carrying amount	$	373.9	$	23.0

Interest expense for the three and six months ended June 30, 2024 and 2023 related to the 2026 Notes and 2025 Notes consisted of the following (in millions):

2026 Notes


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Coupon interest	$	0.1	$	0.1	$	0.2	$	0.2

Amortization of debt issuance costs	0.6		0.6		1.1		1.0
Total interest expense recognized	$	0.7	$	0.7	$	1.3	$	1.2

2025 Notes


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Coupon interest	$	0.1	$	0.1	$	0.1	$	0.1

Amortization of debt issuance costs	—		—		0.1		0.1
Total interest expense recognized	$	0.1	$	0.1	$	0.2	$	0.2

Convertible Notes Hedges

Convertible Notes Warrants

Income Taxes	6 Months Ended
Income Taxes	Jun. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes The Company's effective tax rate was 27.8% and 28.7% for the three and six months ended June 30, 2024, respectively. The effective tax rates for the three and six months ended June 30, 2024 were higher than the U.S. statutory rate of 21.0% primarily due to state taxes, Internal Revenue Code Section 162(m) compensation limitations and foreign operations, partially offset by tax benefits for research credits. The Company’s effective tax rate was 24.9% and 25.8% for the three and six months ended June 30, 2023, respectively. The effective tax rates for the three and six months ended June 30, 2023 were higher than the U.S. statutory rate of 21.0% primarily due to state taxes, Internal Revenue Code Section 162(m) compensation limitations and foreign operations, partially offset by tax benefits for share based compensation deductions, research credits and acquisition adjustments.

Derivatives

6 Months Ended

Jun. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives

Derivatives Not Designated as Hedging Instruments

The notional amounts of the Company’s derivative instruments outstanding were as follows (in millions):


	June 30, 2024 (unaudited)		December 31, 2023
Derivatives not designated as hedges
Foreign exchange contracts	$	29.9	$	26.2
Total derivatives not designated as hedges	$	29.9	$	26.2

Fair Value Measurements	6 Months Ended
Fair Value Measurements	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements The fair value hierarchy is based on inputs to valuation techniques that are used to measure fair value that are either observable or unobservable. Observable inputs reflect assumptions market participants would use in pricing an asset or liability based on market data obtained from independent sources while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions. The fair value hierarchy consists of the following three levels: •Level 1 – Inputs are quoted prices in active markets for identical assets or liabilities. •Level 2 – Inputs are quoted prices for similar assets or liabilities in an active market, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable and market-corroborated inputs which are derived principally from or corroborated by observable market data. •Level 3 – Inputs are derived from valuation techniques in which one or more significant inputs or value drivers are unobservable. The carrying value of cash, cash equivalents and restricted cash, accounts receivable, accounts payable, current liabilities and the revolving line of credit approximate fair value because of the short maturity of these instruments. All highly liquid investments with maturities at date of purchase of three months or less are considered to be cash equivalents. Based on their short-term nature, the carrying value of cash equivalents approximate their fair value. As of June 30, 2024 and December 31, 2023, $55.2 million and $45.3 million, respectively of the Company’s cash, cash equivalents and restricted cash balance related to Level 1 investments. The Company has a deferred compensation plan, which is funded through Company owned life insurance (“COLI”) policies. The COLI asset is carried at fair value derived from quoted market prices of investments within the COLI policies, which are considered Level 2 inputs. The fair value of the COLI asset was $14.3 million and $12.6 million as of June 30, 2024 and December 31, 2023, respectively. The Company estimates the fair value of each foreign exchange forward contract by using the present value of expected cash flows. The estimate takes into account the difference between the current market forward price and contracted forward price for each foreign exchange contract and applies the difference in the rates to each outstanding contract. Valuations for all derivatives fall within Level 2 of the GAAP valuation hierarchy. The fair values of the Company’s derivative instruments outstanding as of June 30, 2024 and December 31, 2023 were immaterial. The Company has contingent consideration liabilities related to acquisitions which are measured on a recurring basis and recorded at fair value, determined using the discounted cash flow method. The inputs used to calculate the fair value of the contingent consideration liabilities are considered to be Level 3 inputs due to the lack of relevant market activity and significant management judgment. An increase in future cash flows may result in a higher estimated fair value while a decrease in future cash flows may result in a lower estimated fair value of the contingent consideration liabilities. Remeasurements to fair value are recorded in adjustment to fair value of contingent consideration in the Unaudited Condensed Consolidated Statements of Operations. Refer to Note 8, Balance Sheet Components, for the estimated fair value of the contingent consideration liabilities as of June 30, 2024 and December 31, 2023. The fair value of the Notes is measured using quoted price inputs. The Notes are not actively traded, and thus the price inputs represent a Level 2 measurement. As the quoted price inputs are highly variable from day to day, the fair value estimates could significantly increase or decrease. The Notes are carried at their principal amount less unamortized issuance costs, and are not carried at fair value at each period end. The approximate fair value of the 2026 Notes as of June 30, 2024 and December 31, 2023 was $368.5 million and $316.1 million, respectively. The approximate fair value of the 2025 Notes as of June 30, 2024 and December 31, 2023 was $34.6 million and $32.4 million, respectively. The fair values were estimated on the basis of inputs that are observable in the market and are considered Level 2 fair value measurements.

Leases

6 Months Ended

Jun. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Leases

Supplemental balance sheet information related to leases was as follows (in millions):


	June 30, 2024 (unaudited)		December 31, 2023
Other current liabilities	$	6.6	$	7.0
Operating lease liabilities	17.4		16.4
Total	$	24.0	$	23.4

Future minimum lease payments as of June 30, 2024 were as follows (in millions):


	June 30, 2024 (unaudited)
2024 remaining	$	3.4
2025	7.4
2026	5.3
2027	4.7
2028	3.7
Thereafter	2.1
Total future lease payments	26.6
Less implied interest	(2.6)
Total	$	24.0

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies From time to time the Company is involved in legal proceedings, claims and litigation related to employee claims, contractual disputes and taxes in the ordinary course of business. Although the Company cannot predict the outcome of such matters, currently the Company has no reason to believe the disposition of any current matter could reasonably be expected to have a material adverse impact on the Company’s financial position, results of operations or the ability to carry on any of its business activities. Since the announcement of the Merger, complaints have been filed by purported stockholders of the Company in the United States District Court for the Southern District of New York (the “Federal Action”), the Circuit Court for St. Louis County in the State of Missouri (the “Missouri Action”), and the Supreme Court of the State of New York, County of New York (the “New York Actions”), in connection with the proposed Merger against us and the members of our Board of Directors and, in the Missouri Action, EQT Asia and certain of its affiliates party to the Merger Agreement in addition to us and the members of our Board of Directors. The Federal Action alleged that the Company and its Board of Directors violated Section 14(a) and Section 20(a) of the Securities Exchange Act of 1934, as amended, by materially omitting and/or misrepresenting certain material facts from the definitive proxy statement that relate to the transactions contemplated by the Merger Agreement. The Missouri Action alleged deficient disclosures and made other claims related to the definitive proxy statement under the state laws of Missouri. The Federal Action and the Missouri Action have been voluntarily dismissed. The New York Actions allege deficient disclosures and make other claims related to the definitive proxy statement under the state laws of New York. Among other remedies, the plaintiffs in each of the remaining complaints may seek to enjoin the consummation of the Merger. We have also received demand letters and draft complaints from purported stockholders of the Company regarding similar subject matter. The Company believes that the claims asserted in the filed complaints and the demand letters are without merit. If the Merger Agreement is terminated under specific circumstances described in the Merger Agreement, we could be required to reimburse certain expenses of Parent or pay Parent a termination fee of $81.3 million. See Note 2, Proposed Merger with Plano HoldCo Inc., an entity wholly-owned by funds affiliated with Baring Private Equity Asia, for further information regarding the Merger.

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net income	$ 17,438	$ 26,362	$ 28,993	$ 53,162

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Jun. 30, 2024
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Terminated	false
Officer and Director Trading Arrangement [Member]
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Company Trading Arrangement [Member]
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

Use of Estimates

Recent Accounting Pronouncements

Revenue from Contract with Customer

Services Revenues

Software and Hardware Revenues

Arrangements with Multiple Performance Obligations

Contract Costs

Stock-Based Compensation

Allowance for Credit Losses

Goodwill and Intangible Assets

Long-term Debt

Revolving Credit Facility

The Company is required to comply with various financial covenants under the 2023 Credit Agreement. At June 30, 2024, the Company was in compliance with all covenants under the 2023 Credit Agreement.

Convertible Senior Notes due 2026

Convertible Senior Notes due 2025

Other Terms of the Notes

•upon the occurrence of certain corporate events or distributions on the Company’s common stock described in the 2025 Indenture and 2026 Indenture; and

The 2025 Notes and 2026 Notes consisted of the following (in millions):


	June 30, 2024 (unaudited)
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3
Less: Unamortized debt issuance costs	(5.1)		(0.2)
Net carrying amount	$	374.9	$	23.1


	December 31, 2023
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3

Less: Unamortized debt issuance costs	(6.1)		(0.3)
Net carrying amount	$	373.9	$	23.0

Interest expense for the three and six months ended June 30, 2024 and 2023 related to the 2026 Notes and 2025 Notes consisted of the following (in millions):

2026 Notes


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Coupon interest	$	0.1	$	0.1	$	0.2	$	0.2

Amortization of debt issuance costs	0.6		0.6		1.1		1.0
Total interest expense recognized	$	0.7	$	0.7	$	1.3	$	1.2

2025 Notes


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Coupon interest	$	0.1	$	0.1	$	0.1	$	0.1

Amortization of debt issuance costs	—		—		0.1		0.1
Total interest expense recognized	$	0.1	$	0.1	$	0.2	$	0.2

Convertible Notes Hedges

Convertible Notes Warrants

Derivatives

Derivatives Not Designated as Hedging Instruments

Fair Value Measurement

based on market data obtained from independent sources while unobservable inputs reflect a reporting entity’s pricing based upon its own market assumptions.

The fair value hierarchy consists of the following three levels:

•Level 1 – Inputs are quoted prices in active markets for identical assets or liabilities.

•Level 3 – Inputs are derived from valuation techniques in which one or more significant inputs or value drivers are unobservable.

Commitments and Contingencies

See Note 2, Proposed Merger with Plano HoldCo Inc., an entity wholly-owned by funds affiliated with Baring Private Equity Asia, for further information regarding the Merger.

Revenue (Tables)

6 Months Ended

Jun. 30, 2024

Revenue from Contract with Customer [Abstract]

Disaggregation of revenue

The following tables present revenue disaggregated by revenue source and pattern of revenue recognition (in millions):


	Three Months Ended June 30,
	2024						2023
	Over Time		Point In Time		Total Revenues		Over Time		Point In Time		Total Revenues
Time and materials contracts	$	160.1	$	—	$	160.1	$	170.6	$	—	$	170.6
Fixed fee percent complete contracts	13.9		—		13.9		16.2		—		16.2
Fixed fee contracts	45.5		—		45.5		41.2		—		41.2
Reimbursable expenses	2.9		—		2.9		2.1		—		2.1
Total professional services fees	222.4		—		222.4		230.1		—		230.1
Other services revenue*	—		0.1		0.1		—		0.6		0.6
Total services	222.4		0.1		222.5		230.1		0.6		230.7
Software and hardware	—		0.3		0.3		—		0.4		0.4
Total revenues	$	222.4	$	0.4	$	222.8	$	230.1	$	1.0	$	231.1

*Other services revenue primarily consists of partner referral fees. These referral fees are recognized at a point in time when earned and recorded within services revenues.


	Six Months Ended June 30,
	2024						2023
	Over Time		Point In Time		Total Revenues		Over Time		Point In Time		Total Revenues
Time and materials contracts	$	314.3	$	—	$	314.3	$	346.1	$	—	$	346.1
Fixed fee percent complete contracts	28.7		—		28.7		31.0		—		31.0
Fixed fee contracts	87.5		—		87.5		78.9		—		78.9
Reimbursable expenses	6.5		—		6.5		4.6		—		4.6
Total professional services fees	437.0		—		437.0		460.6		—		460.6
Other services revenue*	—		0.4		0.4		—		1.0		1.0
Total services	437.0		0.4		437.4		460.6		1.0		461.6
Software and hardware	—		0.7		0.7		—		0.9		0.9
Total revenues	$	437.0	$	1.1	$	438.1	$	460.6	$	1.9	$	462.5

*Other services revenue primarily consists of partner referral fees. These referral fees are recognized at a point in time when earned and recorded within services revenues.

The following table presents revenue disaggregated by geographic area, as determined by the billing address of customers (in millions):


	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
United States	$	211.1	$	223.0	$	416.7	$	446.5
Other countries	11.7		8.1		21.4		16.0
Total revenues	$	222.8	$	231.1	$	438.1	$	462.5

Stock-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2024

Share-Based Payment Arrangement [Abstract]

Restricted stock activity

Restricted stock activity for the six months ended June 30, 2024 was as follows (shares in thousands):


	RSAs (Shares)	Weighted-Average Grant Date Fair Value
Restricted stock awards outstanding at December 31, 2023	714	$	70.80
Awards granted	195	69.00
Awards vested	(197)	73.73
Awards forfeited	(36)	66.25
Restricted stock awards outstanding at June 30, 2024	676	$	69.68

Net Income per Share (Tables)

6 Months Ended

Jun. 30, 2024

Earnings Per Share [Abstract]

Basic and diluted net income per share

The following table presents the calculation of basic and diluted net income per share (in thousands, except per share information):


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Net income, basic	$	17,438	$	26,362	$	28,993	$	53,162
Add back interest expense on convertible notes, net of tax	551		573		1,088		1,133
Net income, diluted	$	17,989	$	26,935	$	30,081	$	54,295

Basic:
Weighted-average shares of common stock outstanding	34,353		33,988		34,251		33,951
Shares used in computing basic net income per share	34,353		33,988		34,251		33,951
Effect of dilutive securities:
Restricted stock and performance stock awards subject to vesting	173		133		175		144
Shares issuable for acquisition consideration (1)	116		166		132		182
Shares issuable for conversion of convertible senior notes	2,430		2,430		2,430		2,430

Shares used in computing diluted net income per share	37,072		36,717		36,988		36,707

Basic net income per share	$	0.51	$	0.78	$	0.85	$	1.57
Diluted net income per share	$	0.49	$	0.73	$	0.81	$	1.48

Antidilutive securities excluded from computation of earnings per share

The number of anti-dilutive securities not included in the calculation of diluted net income per share were as follows (in thousands):


	Three Months Ended		Six Months Ended
	June 30,		June 30,
	2024	2023	2024	2023
Restricted stock and performance stock awards subject to vesting	121	144	115	210

Warrants related to the issuance of convertible senior notes	2,431	2,431	2,431	2,431
Total anti-dilutive securities	2,552	2,575	2,546	2,641

Balance Sheet Components (Tables)

6 Months Ended

Jun. 30, 2024

Balance Sheet Related Disclosures [Abstract]

Accounts receivable


	June 30, 2024 (unaudited)		December 31, 2023
Accounts receivable:	(in millions)
Billed accounts receivable, net	$	96.1	$	119.9
Unbilled revenues, net	99.9		59.1
Total	$	196.0	$	179.0

Other current assets



Other non-current assets:
Non-current unbilled revenue	$	1.4	$	2.2
Company owned life insurance asset	14.3		12.6
Long term deposits	1.9		1.8
Credit facility deferred financing fees, net	0.9		1.0
Other non-current assets	17.1		13.2
Deferred income taxes	28.9		21.6
Total	$	64.5	$	52.4

Property and equipment


Property and equipment:
Computer hardware (useful life of 3 years)	$	25.1	$	26.7
Software (useful life of 1 to 7 years)	8.7		9.2
Furniture and fixtures (useful life of 5 years)	4.3		4.5
Leasehold improvements (useful life of 5 years)	7.6		7.8
Less: Accumulated depreciation	(37.2)		(36.2)
Total	$	8.5	$	12.0

Other non-current assets


Other current assets:
Miscellaneous receivables	$	3.6	$	3.1
Contractual commitment asset	5.1		3.0
Income tax receivable	10.5		2.7
Other current assets	4.1		3.6
Total	$	23.3	$	12.4

Other current liabilities



Other current liabilities:
Estimated fair value of contingent consideration liability (Note 10)	$	6.5	$	4.5
Accrued variable compensation	22.1		15.9
Current operating lease liabilities	6.6		7.0
Payroll related costs	12.1		11.1
Deferred revenues	1.6		5.5
Income tax payable	1.3		1.5
Other current liabilities	7.1		4.8
Accrued medical claims expense	2.3		3.2
Professional fees	3.3		1.3
Accrued IT expenses	3.5		5.0
Total	$	66.4	$	59.8

Other non-current liabilities


	June 30, 2024 (unaudited)		December 31, 2023
Other non-current liabilities:	(in millions)
Deferred income taxes	$	4.8	$	5.9
Reserve for uncertain tax positions	19.0		17.7
Deferred compensation liability	12.5		11.0
Other non-current liabilities	7.6		5.0
Non-current software accrual	1.7		2.6
Total	$	45.6	$	42.2

Allowance for Credit Losses (Tables)

6 Months Ended

Jun. 30, 2024

Credit Loss [Abstract]

Allowance for credit losses

Activity in the allowance for credit losses is summarized as follows (in millions):


	Six Months Ended June 30,
	2024		2023


Opening balance at January 1	$	2.5	$	5.8
Charges to expense, net of recoveries	0.2		(0.3)
Other (1)	(0.2)		(2.0)
Balance at June 30	$	2.5	$	3.5

(1) Other is primarily related to uncollected balances written off and currency translation adjustments.

Business Combinations (Tables)

6 Months Ended

Jun. 30, 2024

Business Combinations [Abstract]

Allocation of total purchase price consideration

The acquisition date fair value of the consideration transferred for SMEDIX consisted of the following (in millions):


	SMEDIX
Cash, net of cash acquired	$	32.9
Company common stock issued at closing	3.8
Contingent consideration (1)	6.4		(2)
Net working capital adjustment due to the seller(s)	0.2
Total allocable purchase price consideration	$	43.3

(2)The maximum cash payout that may be realized by the sellers in the SMEDIX acquisition is $14.4 million. As of June 30, 2024, the fair value of the contingent consideration was $6.5 million.


	SMEDIX
Acquired tangible assets	$	5.1
Identified intangible assets	8.9
Liabilities assumed	(3.2)
Goodwill	32.5
Total allocable purchase price consideration	$	43.3

Schedule of finite-lived intangible assets acquired

The following table presents details of the intangible assets acquired during the three months ended June 30, 2024.

Weighted Average Useful Life

Estimated Useful Life

SMEDIX

Customer relationships

6 years

7.0

Customer backlog

1 year

1.7

Non-compete agreements

5 years

0.1

Trade name

1 year

0.1

Total acquired intangible assets

8.9

Goodwill and Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2024

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill

The changes in the carrying amount of goodwill for the six months ended June 30, 2024 are as follows (in millions):


Balance at December 31, 2023	$	581.4
Purchase price allocation for SMEDIX	32.5
Effect of foreign currency translation adjustments	(5.1)
Balance at June 30, 2024	$	608.8

Intangible assets

The following table presents a summary of the Company’s intangible assets that are subject to amortization (in millions):


	June 30, 2024 (unaudited)						December 31, 2023
	Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts		Gross Carrying Amounts		Accumulated Amortization		Net Carrying Amounts
Customer relationships	$	114.2	$	(46.7)	$	67.5	$	116.1	$	(47.3)	$	68.8
Non-compete agreements	1.2		(0.7)		0.5		1.1		(0.6)		0.5
Customer backlog	1.7		(0.8)		0.9		—		—		—
Trade name	0.9		(0.8)		0.1		0.8		(0.8)		—
Developed software	9.1		(7.6)		1.5		8.5		(6.7)		1.8
Total	$	127.1	$	(56.6)	$	70.5	$	126.5	$	(55.4)	$	71.1

Estimated useful lives of intangible assets

The estimated useful lives of identifiable intangible assets are as follows:


Customer relationships			5 - 10 years
Non-compete agreements			4 - 5 years
Customer backlog			1 year
Trade name			1 year
Developed software			1 - 7 years

Estimated annual amortization expense

Estimated annual amortization expense for the next five years ended December 31 and thereafter is as follows (in millions):


2024 remaining	$	9.0
2025	$	13.4
2026	$	10.9
2027	$	8.5
2028	$	7.4
Thereafter	$	21.3

Long-term Debt (Tables)

6 Months Ended

Jun. 30, 2024

Debt Disclosure [Abstract]

Schedule of long-term debt instruments

The 2025 Notes and 2026 Notes consisted of the following (in millions):


	June 30, 2024 (unaudited)
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3
Less: Unamortized debt issuance costs	(5.1)		(0.2)
Net carrying amount	$	374.9	$	23.1


	December 31, 2023
Long-term debt:	2026 Notes		2025 Notes
Principal	$	380.0	$	23.3

Less: Unamortized debt issuance costs	(6.1)		(0.3)
Net carrying amount	$	373.9	$	23.0

Interest expense for the three and six months ended June 30, 2024 and 2023 related to the 2026 Notes and 2025 Notes consisted of the following (in millions):

2026 Notes


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Coupon interest	$	0.1	$	0.1	$	0.2	$	0.2

Amortization of debt issuance costs	0.6		0.6		1.1		1.0
Total interest expense recognized	$	0.7	$	0.7	$	1.3	$	1.2

2025 Notes


	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Coupon interest	$	0.1	$	0.1	$	0.1	$	0.1

Amortization of debt issuance costs	—		—		0.1		0.1
Total interest expense recognized	$	0.1	$	0.1	$	0.2	$	0.2

Derivatives (Tables)

6 Months Ended

Jun. 30, 2024

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of notional amounts of outstanding derivative positions

The notional amounts of the Company’s derivative instruments outstanding were as follows (in millions):


	June 30, 2024 (unaudited)		December 31, 2023
Derivatives not designated as hedges
Foreign exchange contracts	$	29.9	$	26.2
Total derivatives not designated as hedges	$	29.9	$	26.2

Leases (Tables)

6 Months Ended

Jun. 30, 2024

Commitments and Contingencies Disclosure [Abstract]

Summary of lease liabilities

Supplemental balance sheet information related to leases was as follows (in millions):


	June 30, 2024 (unaudited)		December 31, 2023
Other current liabilities	$	6.6	$	7.0
Operating lease liabilities	17.4		16.4
Total	$	24.0	$	23.4

Future minimum leases payments under ASC topic 842

Future minimum lease payments as of June 30, 2024 were as follows (in millions):


	June 30, 2024 (unaudited)
2024 remaining	$	3.4
2025	7.4
2026	5.3
2027	4.7
2028	3.7
Thereafter	2.1
Total future lease payments	26.6
Less implied interest	(2.6)
Total	$	24.0

Proposed Merger with Plano HoldCo Inc., an entity wholly-owned by funds affiliated with Baring Private Equity Asia (Details) $ / shares in Units, $ in Millions	May 05, 2024 USD ($) $ / shares
Business Acquisition [Line Items]
Cash paid per share in business acquisition (in dollars per share) \| $ / shares	$ 76.00
Termination fee	$ 81.3
Plano Holdco, Inc.
Business Acquisition [Line Items]
Termination fee	$ 162.6

Revenue - Services Revenue (Details) - Technology Service	6 Months Ended
	Jun. 30, 2024
Minimum
Disaggregation of Revenue [Line Items]
Notice period to cancel or terminate contract	10 days
Maximum
Disaggregation of Revenue [Line Items]
Notice period to cancel or terminate contract	30 days

Revenue - Deferred Revenue (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Revenue from Contract with Customer [Abstract]
Deferred revenue balance	$ 1.6	$ 5.5

Revenue - Disaggregation of Revenue by Revenue Source and Pattern of Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disaggregation of Revenue [Line Items]
Revenues	$ 222,817	$ 231,105	$ 438,121	$ 462,513
Over Time
Disaggregation of Revenue [Line Items]
Revenues	222,400	230,100	437,000	460,600
Point In Time
Disaggregation of Revenue [Line Items]
Revenues	400	1,000	1,100	1,900
Services
Disaggregation of Revenue [Line Items]
Revenues	222,500	230,700	437,400	461,600
Services \| Over Time
Disaggregation of Revenue [Line Items]
Revenues	222,400	230,100	437,000	460,600
Services \| Point In Time
Disaggregation of Revenue [Line Items]
Revenues	100	600	400	1,000
Professional services
Disaggregation of Revenue [Line Items]
Revenues	222,400	230,100	437,000	460,600
Professional services \| Over Time
Disaggregation of Revenue [Line Items]
Revenues	222,400	230,100	437,000	460,600
Professional services \| Point In Time
Disaggregation of Revenue [Line Items]
Revenues	0	0	0	0
Professional services \| Time and materials contracts
Disaggregation of Revenue [Line Items]
Revenues	160,100	170,600	314,300	346,100
Professional services \| Time and materials contracts \| Over Time
Disaggregation of Revenue [Line Items]
Revenues	160,100	170,600	314,300	346,100
Professional services \| Time and materials contracts \| Point In Time
Disaggregation of Revenue [Line Items]
Revenues	0	0	0	0
Professional services \| Fixed fee percent complete contracts
Disaggregation of Revenue [Line Items]
Revenues	13,900	16,200	28,700	31,000
Professional services \| Fixed fee percent complete contracts \| Over Time
Disaggregation of Revenue [Line Items]
Revenues	13,900	16,200	28,700	31,000
Professional services \| Fixed fee percent complete contracts \| Point In Time
Disaggregation of Revenue [Line Items]
Revenues	0	0	0	0
Professional services \| Fixed fee contracts
Disaggregation of Revenue [Line Items]
Revenues	45,500	41,200	87,500	78,900
Professional services \| Fixed fee contracts \| Over Time
Disaggregation of Revenue [Line Items]
Revenues	45,500	41,200	87,500	78,900
Professional services \| Fixed fee contracts \| Point In Time
Disaggregation of Revenue [Line Items]
Revenues	0	0	0	0
Professional services \| Reimbursable expenses
Disaggregation of Revenue [Line Items]
Revenues	2,900	2,100	6,500	4,600
Professional services \| Reimbursable expenses \| Over Time
Disaggregation of Revenue [Line Items]
Revenues	2,900	2,100	6,500	4,600
Professional services \| Reimbursable expenses \| Point In Time
Disaggregation of Revenue [Line Items]
Revenues	0	0	0	0
Other services
Disaggregation of Revenue [Line Items]
Revenues	100	600	400	1,000
Other services \| Over Time
Disaggregation of Revenue [Line Items]
Revenues	0	0	0	0
Other services \| Point In Time
Disaggregation of Revenue [Line Items]
Revenues	100	600	400	1,000
Software and hardware
Disaggregation of Revenue [Line Items]
Revenues	300	400	700	900
Software and hardware \| Over Time
Disaggregation of Revenue [Line Items]
Revenues	0	0	0	0
Software and hardware \| Point In Time
Disaggregation of Revenue [Line Items]
Revenues	$ 300	$ 400	$ 700	$ 900

Revenue - Disaggregation of Revenue by Geographic Area (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disaggregation of Revenue [Line Items]
Revenues	$ 222,817	$ 231,105	$ 438,121	$ 462,513
United States
Disaggregation of Revenue [Line Items]
Revenues	211,100	223,000	416,700	446,500
Other countries
Disaggregation of Revenue [Line Items]
Revenues	$ 11,700	$ 8,100	$ 21,400	$ 16,000

Stock-Based Compensation - Stock Award Plans (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Stock-Based Compensation [Abstract]
Requisite service period (in years)			3 years
Stock compensation	$ 6.3	$ 7.4	$ 18.7	$ 14.2
Stock-based compensation expense for retirement savings plan contributions	1.2	1.3	2.2	2.4
Associated current and future income tax benefits recognized	1.7	$ 1.9	5.4	$ 3.7
Incremental share based compensation expense			5.6
Performance Stock Awards
Stock-Based Compensation [Abstract]
Stock compensation	0.1
Total unrecognized compensation cost related to non-vested share-based awards	0.6		$ 0.6
Unrecognized compensation cost, weighted-average period for recognition (in years)			3 years
Restricted stock and performance stock awards subject to vesting
Stock-Based Compensation [Abstract]
Total unrecognized compensation cost related to non-vested share-based awards	$ 31.2		$ 31.2
Unrecognized compensation cost, weighted-average period for recognition (in years)			2 years
2012 Long term incentive plan
Stock-Based Compensation [Abstract]
Maximum number of shares authorized under plan (in shares)	8.5		8.5
Number of shares available for issuance under the incentive plan (in shares)	1.9		1.9

Stock-Based Compensation - Restricted Stock Activity (Details)	6 Months Ended
	Jun. 30, 2024 $ / shares shares
Performance Stock Awards
RSAs (Shares)
Awards granted (in shares) \| shares	10,842
Weighted-Average Grant Date Fair Value
Awards granted (in dollars per share) \| $ / shares	$ 80.90
2012 Long term incentive plan \| Restricted stock and performance stock awards subject to vesting
RSAs (Shares)
Restricted stock awards outstanding at beginning of period (in shares) \| shares	714,000
Awards granted (in shares) \| shares	195,000
Awards vested (in shares) \| shares	(197,000)
Awards forfeited (in shares) \| shares	(36,000)
Restricted stock awards outstanding at end of period (in shares) \| shares	676,000
Weighted-Average Grant Date Fair Value
Awards outstanding at beginning of period (in dollars per share) \| $ / shares	$ 70.80
Awards granted (in dollars per share) \| $ / shares	69.00
Awards vested (in dollars per share) \| $ / shares	73.73
Awards forfeited (in dollars per share) \| $ / shares	66.25
Awards outstanding at end of period (in dollars per share) \| $ / shares	$ 69.68

Net Income per Share - Basic and Diluted (Details) - USD ($) $ / shares in Units, shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Earnings Per Share [Abstract]
Net income	$ 17,438,000	$ 26,362,000	$ 28,993,000	$ 53,162,000
Add back interest expense on convertible notes, net of tax	551,000	573,000	1,088,000	1,133,000
Net income, diluted	$ 17,989,000	$ 26,935,000	$ 30,081,000	$ 54,295,000
Basic:
Weighted-average shares of common stock outstanding	34,353	33,988	34,251	33,951
Shares used in computing basic net income per share	34,353	33,988	34,251	33,951
Effect of dilutive securities:
Restricted stock and performance stock awards subject to vesting	173	133	175	144
Shares issuable for acquisition consideration (in shares)	116	166	132	182
Shares issuable for conversion of convertible senior notes (in shares)	2,430	2,430	2,430	2,430
Shares used in computing diluted net income per share	37,072	36,717	36,988	36,707
Basic net income per share (in dollars per share)	$ 0.51	$ 0.78	$ 0.85	$ 1.57
Diluted net income per share (in dollars per share)	$ 0.49	$ 0.73	$ 0.81	$ 1.48
Shares authorized to repurchase					$ 375,000,000.0

Net Income per Share - Anti-dilutive Securities (Details) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	2,552	2,575	2,546	2,641
Restricted stock and performance stock awards subject to vesting
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	121	144	115	210
Warrants related to the issuance of convertible senior notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive securities	2,431	2,431	2,431	2,431

Net Income per Share - Additional Information (Details) - USD ($) shares in Millions	Jun. 30, 2024	Dec. 31, 2023
Earnings Per Share [Abstract]
Shares authorized to repurchase		$ 375,000,000.0
Cumulative amount repurchased	$ 291,100,000
Cumulative number of shares repurchased (in shares)	16.5

Balance Sheet Components - Accounts Receivable (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Balance Sheet Related Disclosures [Abstract]
Billed accounts receivable, net	$ 96,100	$ 119,900
Unbilled revenues, net	99,900	59,100
Total	$ 195,954	$ 178,998

Balance Sheet Components - Other Current Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Offsetting [Abstract]
Miscellaneous receivables	$ 3,600	$ 3,100
Contractual commitment asset	5,100	3,000
Income tax receivable	10,500	2,700
Other current assets	4,100	3,600
Other current assets	$ 23,298	$ 12,431

Balance Sheet Components - Property and Equipment) (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Property and Equipment [Abstract]
Less: Accumulated depreciation	$ (37,200)	$ (36,200)
Property and equipment, net	8,504	11,996
Computer hardware
Property and Equipment [Abstract]
Property and equipment	$ 25,100	26,700
Useful life	3 years
Software
Property and Equipment [Abstract]
Property and equipment	$ 8,700	9,200
Furniture and fixtures
Property and Equipment [Abstract]
Property and equipment	$ 4,300	4,500
Useful life	5 years
Leasehold improvements
Property and Equipment [Abstract]
Property and equipment	$ 7,600	$ 7,800
Useful life	5 years
Minimum \| Software
Property and Equipment [Abstract]
Useful life	1 year
Maximum \| Software
Property and Equipment [Abstract]
Useful life	7 years

Balance Sheet Components - Other Non-current Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Offsetting [Abstract]
Non-current unbilled revenue	$ 1,400	$ 2,200
Company owned life insurance asset	14,300	12,600
Long term deposits	1,900	1,800
Credit facility deferred financing fees, net	900	1,000
Other non-current assets	17,100	13,200
Deferred income taxes	28,900	21,600
Other non-current assets	$ 64,542	$ 52,364

Balance Sheet Components - Other Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Other current liabilities:
Estimated fair value of contingent consideration liability	$ 6,500	$ 4,500
Accrued variable compensation	22,100	15,900
Current operating lease liabilities	6,600	7,000
Payroll related costs	12,100	11,100
Deferred revenues	1,600	5,500
Income tax payable	1,300	1,500
Other current liabilities	7,100	4,800
Accrued medical claims expense	2,300	3,200
Professional fees	3,300	1,300
Accrued IT expenses	3,500	5,000
Total	$ 66,355	$ 59,784

Balance Sheet Components - Other Non-Current Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Other non-current liabilities:
Deferred income taxes	$ 4,800	$ 5,900
Unrecognized Tax Benefits, Income Tax Penalties Accrued	19,000	17,700
Deferred compensation liability	12,500	11,000
Non-current software accrual	1,700	2,600
Other non-current liabilities	7,600	5,000
Total	$ 45,600	$ 42,189

Allowance for Credit Losses (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Accounts Receivable, Allowance for Credit Loss [Roll Forward]
Beginning balance	$ 2,500	$ 5,800
Charges to expense, net of recoveries	200	(300)
Other (1)	(200)	(2,000)
Balance at June 30	$ 2,500	$ 3,500

Business Combinations - Narrative (Details) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
	Jan. 16, 2024	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Business Acquisition [Line Items]
Acquisition costs		$ 132	$ (71)	$ 1,050	$ 8
SMEDIX
Business Acquisition [Line Items]
Total purchase price	$ 43,300
Acquisition costs	1,700
Tax deductible amount of Goodwill	$ 33,400

Business Combinations - SMEDIX (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Jan. 16, 2024	Dec. 31, 2023
Business Acquisition [Line Items]
Goodwill	$ 608,774		$ 581,387
SMEDIX
Business Acquisition [Line Items]
Cash paid for acquisition		$ 32,900
Company common stock issued at closing		3,800
Initial fair value estimate of additional earnings-based contingent consideration	$ 6,500	6,400
Net working capital settlement		200
Total purchase price		43,300
Contingent consideration, maximum cash payout		14,400
Acquired tangible assets		5,100
Identified intangible assets		8,900
Liabilities assumed		(3,200)
Goodwill		$ 32,500

Business Combinations - Intangible Assets Acquired (Details) - SMEDIX $ in Millions	6 Months Ended
	Jun. 30, 2023 USD ($)
Finite-Lived Intangible Assets, Gross [Abstract]
SMEDIX	$ 8.9
Customer relationships
Finite-Lived Intangible Assets, Gross [Abstract]
Weighted Average Useful Life	6 years
Estimated Useful Life	6 years
SMEDIX	$ 7.0
Customer backlog
Finite-Lived Intangible Assets, Gross [Abstract]
Weighted Average Useful Life	1 year
Estimated Useful Life	1 year
SMEDIX	$ 1.7
Non-compete agreements
Finite-Lived Intangible Assets, Gross [Abstract]
Weighted Average Useful Life	5 years
Estimated Useful Life	5 years
SMEDIX	$ 0.1
Trade name
Finite-Lived Intangible Assets, Gross [Abstract]
Weighted Average Useful Life	1 year
Estimated Useful Life	1 year
SMEDIX	$ 0.1

Goodwill and Intangible Assets - Goodwill (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2024 USD ($)
Goodwill [Roll Forward]
Balance at December 31, 2023	$ 581,387
Purchase price allocation for SMEDIX	32,500
Effect of foreign currency translation adjustments	(5,100)
Balance at June 30, 2024	$ 608,774

Goodwill and Intangible Assets - Intangible Assets (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets, Net [Abstract]
Gross Carrying Amounts	$ 127,100	$ 126,500
Accumulated Amortization	(56,600)	(55,400)
Net Carrying Amounts	70,529	71,118
Customer relationships
Finite-Lived Intangible Assets, Net [Abstract]
Gross Carrying Amounts	114,200	116,100
Accumulated Amortization	(46,700)	(47,300)
Net Carrying Amounts	67,500	68,800
Non-compete agreements
Finite-Lived Intangible Assets, Net [Abstract]
Gross Carrying Amounts	1,200	1,100
Accumulated Amortization	(700)	(600)
Net Carrying Amounts	500	500
Customer backlog
Finite-Lived Intangible Assets, Net [Abstract]
Gross Carrying Amounts	1,700	0
Accumulated Amortization	(800)	0
Net Carrying Amounts	900	0
Trade name
Finite-Lived Intangible Assets, Net [Abstract]
Gross Carrying Amounts	900	800
Accumulated Amortization	(800)	(800)
Net Carrying Amounts	100	0
Developed software
Finite-Lived Intangible Assets, Net [Abstract]
Gross Carrying Amounts	9,100	8,500
Accumulated Amortization	(7,600)	(6,700)
Net Carrying Amounts	$ 1,500	$ 1,800

Goodwill and Intangible Assets - Estimated Useful Lives (Details)	Jun. 30, 2024
Customer relationships \| Minimum
Intangible Assets [Abstract]
Estimated useful lives (in years)	5 years
Customer relationships \| Maximum
Intangible Assets [Abstract]
Estimated useful lives (in years)	10 years
Non-compete agreements \| Minimum
Intangible Assets [Abstract]
Estimated useful lives (in years)	4 years
Non-compete agreements \| Maximum
Intangible Assets [Abstract]
Estimated useful lives (in years)	5 years
Customer backlog
Intangible Assets [Abstract]
Estimated useful lives (in years)	1 year
Trade name
Intangible Assets [Abstract]
Estimated useful lives (in years)	1 year
Developed software \| Minimum
Intangible Assets [Abstract]
Estimated useful lives (in years)	1 year
Developed software \| Maximum
Intangible Assets [Abstract]
Estimated useful lives (in years)	7 years

Goodwill and Intangible Assets - Estimated Amortization Expense (Details) $ in Millions	Jun. 30, 2024 USD ($)
Estimated Amortization Expense [Abstract]
2024 remaining	$ 9.0
2025	13.4
2026	10.9
2027	8.5
2028	7.4
Thereafter	$ 21.3

Long-term Debt - Revolving Credit Facility (Details) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Mar. 29, 2023
Line of Credit [Abstract]
Payment for credit facility financing fees	$ 0	$ 750,000
Convertible debt \| Minimum
Line of Credit [Abstract]
Line of Credit Facility, Commitment Fee Percentage	0.15%
Convertible debt \| Maximum
Line of Credit [Abstract]
Line of Credit Facility, Commitment Fee Percentage	0.20%
Conversion Circumstance One \| Convertible debt
Line of Credit [Abstract]
Conversion rate of the notes on trading day (as percent)	130.00%
Revolving credit facility \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Minimum
Line of Credit [Abstract]
Margin interest rate percentage	1.00%
Revolving credit facility \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate \| Maximum
Line of Credit [Abstract]
Margin interest rate percentage	2.00%
Revolving credit facility \| Credit agreement
Line of Credit [Abstract]
Allowable amount of letters of credit for issuance	$ 10,000,000.0
Additional commitment increase	75,000,000.0
Maximum borrowing capacity			$ 300,000,000.0
Payment for credit facility financing fees		$ 800,000
Available borrowing capacity	$ 300,000,000.0
Revolving credit facility \| Credit agreement \| Prime rate
Line of Credit [Abstract]
Interest rate at end of period	8.50%
Revolving credit facility \| Credit agreement \| Prime rate \| Minimum
Line of Credit [Abstract]
Margin interest rate percentage	0.00%
Revolving credit facility \| Credit agreement \| Prime rate \| Maximum
Line of Credit [Abstract]
Margin interest rate percentage	1.00%
Revolving credit facility \| Credit agreement \| Secured Overnight Financing Rate (SOFR) Overnight Index Swap Rate
Line of Credit [Abstract]
Interest rate at end of period	5.33%

Long-term Debt - Convertible Senior Notes (Additional Notes) (Details) $ / shares in Units, $ in Thousands			6 Months Ended
	Nov. 09, 2021 USD ($) $ / shares	Aug. 14, 2020 USD ($) $ / shares	Jun. 30, 2024 USD ($) day $ / shares Rate	Dec. 31, 2023 USD ($)
Debt Instrument [Line Items]
Share price at closing (in dollars per share) \| $ / shares			$ 74.79
Retained earnings			$ 506,189	$ 477,196
Long-term debt, net			$ 398,018	396,874
2025 Notes \| Warrants related to the issuance of convertible senior notes
Debt Instrument [Line Items]
Warrant exercise price (in dollars per share) \| $ / shares			$ 81.05
2026 Notes \| Warrants related to the issuance of convertible senior notes
Debt Instrument [Line Items]
Warrant exercise price (in dollars per share) \| $ / shares			$ 295.29
Convertible debt \| Conversion Circumstance One
Debt Instrument [Line Items]
Conversion rate of the notes on trading day (as percent)			130.00%
Threshold trading days (whether or not consecutive) \| day			20
Consecutive trading day period (in days) \| day			30
Convertible debt \| Conversion Circumstance Two
Debt Instrument [Line Items]
Conversion rate of the notes on trading day (as percent) \| Rate			98.00%
Threshold trading days (whether or not consecutive) \| day			5
Consecutive trading day period (in days) \| day			10
Convertible debt \| 2025 Notes
Debt Instrument [Line Items]
Aggregated principal amount		$ 230,000
Interest rate stated, percentage		1.25%
Shares conversion rate		19.3538
Initial conversion price (in dollars per share) \| $ / shares		$ 51.67
Principal			$ 23,300	23,300
Long-term debt, net			$ 23,100	23,000
Convertible debt \| 2026 Notes
Debt Instrument [Line Items]
Aggregated principal amount	$ 380,000
Interest rate stated, percentage			0.125%
Shares conversion rate	5.2100
Initial conversion price (in dollars per share) \| $ / shares	$ 191.94
Principal			$ 380,000	380,000
Long-term debt, net			$ 374,900	$ 373,900

Long-term Debt - Liability and Equity Component of Note (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Long-term debt:
Net carrying amount	$ 398,018	$ 396,874
Convertible debt \| 2025 Notes
Long-term debt:
Principal	23,300	23,300
Less: Unamortized debt issuance costs	(200)	(300)
Net carrying amount	23,100	23,000
Convertible debt \| 2026 Notes
Long-term debt:
Principal	380,000	380,000
Less: Unamortized debt issuance costs	(5,100)	(6,100)
Net carrying amount	$ 374,900	$ 373,900

Long-term Debt - Interest Expense on Note (Details) - Senior notes - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
2025 Notes
Debt Instrument [Line Items]
Coupon interest	$ 100	$ 100	$ 100	$ 100
Amortization of debt issuance costs	0	0	100	100
Total interest expense recognized	100	100	200	200
2026 Notes
Debt Instrument [Line Items]
Coupon interest	100	100	200	200
Amortization of debt issuance costs	600	600	1,100	1,000
Total interest expense recognized	$ 700	$ 700	$ 1,300	$ 1,200

Long-term Debt - Convertible Note Hedges and Warrants (Details) - $ / shares shares in Millions			6 Months Ended
	Nov. 09, 2021	Aug. 14, 2020	Jun. 30, 2024
2025 Notes
Debt Instrument [Line Items]
Expiration period for Notes Warrants in trading days			100 days
2026 Notes
Debt Instrument [Line Items]
Expiration period for Notes Warrants in trading days			80 days
Convertible note hedges \| 2025 Notes
Debt Instrument [Line Items]
Conversion option to acquire shares (in shares)			0.5
Strike price (in dollars per share)		$ 51.67
Convertible note hedges \| 2026 Notes
Debt Instrument [Line Items]
Conversion option to acquire shares (in shares)			2.0
Strike price (in dollars per share)	$ 191.94
Warrant \| 2025 Notes
Debt Instrument [Line Items]
Warrant exercise price (in dollars per share)			$ 81.05
Warrant \| 2026 Notes
Debt Instrument [Line Items]
Warrant exercise price (in dollars per share)			$ 295.29

Income Taxes (Details)	3 Months Ended		6 Months Ended
Income Taxes (Details)	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Tax Disclosure [Abstract]
Effective tax rate	27.80%	24.90%	28.70%	25.80%

Derivatives - Notional Amounts (Details) - Total derivatives not designated as hedges - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Notional Disclosures [Abstract]
Derivative notional amounts	$ 29,900		$ 29,900		$ 26,200
Gain (Loss) on Foreign Currency Derivatives Recorded in Earnings, Net	(1,000)	$ 1,200	(1,200)	$ 1,600
Foreign exchange contracts
Notional Disclosures [Abstract]
Derivative notional amounts	$ 29,900		$ 29,900		$ 26,200

Fair Value Measurements (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
COLI asset	$ 14.3	$ 12.6
Level 2 \| 2025 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Note, debt instrument	34.6	32.4
Level 2 \| 2026 Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Note, debt instrument	368.5	316.1
Money market funds \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	$ 55.2	$ 45.3

Leases - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
Leases - Narrative (Details) - USD ($) $ in Millions	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Lessee, Lease, Description [Line Items]
Operating lease expense	$ 3.1	$ 3.2	$ 6.1	$ 6.5
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease terms (in years)	1 year		1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease terms (in years)	7 years		7 years

Leases - Lease Liabilities (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Leases [Abstract]
Other current liabilities	$ 6,600	$ 7,000
Operating lease liabilities	17,420	16,446
Total	$ 24,000	$ 23,400

Leases - Future Minimum Lease Payments under ASC Topic 842 (Details) - USD ($) $ in Millions	Jun. 30, 2024	Dec. 31, 2023
Commitments and Contingencies Disclosure [Abstract]
2024 remaining	$ 3.4
2025	7.4
2026	5.3
2027	4.7
2028	3.7
Thereafter	2.1
Total future lease payments	26.6
Less implied interest	(2.6)
Total	$ 24.0	$ 23.4